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The objective of this research was to design and fabricate a nose-on-chip device 
and bi-directional airflow system that models flow within the nasal cavity to investigate 
how airflow induced mechanical stresses impact nasal secretion rates and cytoskeletal 
remodeling. This research hypothesizes that the airflow induced shear stresses on the 
nasal mucosa will influence mucus production and the cytoskeleton of the cells. The 
RPMI 2650 cell line was used to model the nasal mucosa. The system was used to 
replicate the wall shear stresses (WSS) and wall shear forces (WSF) present in the 
anterior region of the nose. The WSS and WSF within the device were validated using 
calculations and CFD simulation. It was found that the WSS and WSF increase mucus 
secretion with higher durations of exposure and influence cytoskeletal integrity. A 
prediction equation was derived to predict the mucus production of RPMI 2650 cells 







TABLE OF CONTENTS 
 
1.  INTRODUCTION ....................................................................................................... 1 
1.1 Motivation for Research ....................................................................................... 1 
1.2 Impact of toxins on upper respiratory system ...................................................... 1 
1.3 Environmental threats to airmen and civilians ..................................................... 2 
1.4 Nasal Mucosa Background................................................................................... 4 
1.4.1 Purpose of mucus membrane/mucus production .......................................... 4 
1.4.2 Structure of nasal mucosa: Cells and Proteins .............................................. 6 
1.4.3 Airflow Characteristics in Different Nasal Regions ..................................... 7 
1.4.4 How shear stress effects nasal mucosa ......................................................... 9 
1.5 RPMI 2650 Cell Line ......................................................................................... 10 
1.6 Dish culture models ............................................................................................ 11 
1.6.1 Pros ............................................................................................................. 11 
1.6.2 Cons ............................................................................................................ 11 
1.7 The Need for Microfluidics ................................................................................ 12 
1.8 Microfluidics Models of the Respiratory System .............................................. 13 
1.9 Benefit of Microfluidic Devices ......................................................................... 13 
2. MATERIALS AND METHODS .............................................................................. 15 
v 
 
2.1 Overview ............................................................................................................ 15 
2.2 Nose-On-Chip Device and Transwell Inserts..................................................... 15 
2.2.1 Device Overview ........................................................................................ 15 
2.2.2 Device Components .................................................................................... 16 
2.2.3 Fabrication .................................................................................................. 20 
 Nose-on-Chip Device Fabrication ........................................................... 20 
 Transwell Insert Fabrication.................................................................... 22 
2.2.3.2.1 Transwell Supports ............................................................................ 22 
2.2.3.2.2 Transwell Membranes ....................................................................... 23 
2.2.3.2.3 Completed Transwell Insert ............................................................... 25 
 Device Operation..................................................................................... 26 
2.3 Bi-Directional Air Delivery System ................................................................... 28 
2.3.1 Air Delivery System Components .............................................................. 30 
2.3.2 Air Delivery System Operation .................................................................. 35 
2.4 Computational Fluid Dynamics Simulations ..................................................... 36 
2.5 Flow Calculations ............................................................................................... 39 
2.6 RPMI 2650 Cell Cultivation .............................................................................. 45 
2.7 Experimental Procedures.................................................................................... 47 
2.7.1 Alcian Blue Staining Procedure .................................................................. 49 
2.7.2 β-tubulin and actin immunocytochemistry ................................................. 50 
vi 
 
3. RESULTS AND DISCUSSION................................................................................ 52 
3.1 PDMS Membrane Evaluation ............................................................................ 52 
3.1.1 PDMS Membrane Characteristics ............................................................... 52 
3.1.2 Membrane Thickness .................................................................................. 54 
3.1.3 Results and Discussion ............................................................................... 55 
3.2 Effects of Wall Shear Stresses and Wall Shear Forces on Mucus Production ... 56 
3.2.1 ImageJ analysis ........................................................................................... 56 
3.2.2 Mucus Production Prediction Equation ...................................................... 58 
3.2.3 Results and Discussion ............................................................................... 60 
3.3 Effects of Shear Stresses on Cytoskeletal Remodeling ...................................... 63 
3.3.1 β-tubulin and Actin Immunocytochemistry ................................................ 63 
3.3.2 Results and Discussion ............................................................................... 65 
3.4 Nose-on-Chip Airflow Channel Optimization ................................................... 65 
3.4.1 Calculations................................................................................................. 66 
3.4.2 CFD Simulations ......................................................................................... 67 
3.4.3 Results and Discussion ............................................................................... 71 
4. CONCLUSION ......................................................................................................... 75 
5. APPENDIX ............................................................................................................... 77 




LIST OF FIGURES 
Figure                                                                                                                             Page 
Figure 1: Diagram of the Nasal Cavity Regions (13) ......................................................... 6 
Figure 2: Overview of the Nose-on-Chip device components .......................................... 17 
Figure 3: 3D model of the custom transwell support ........................................................ 19 
Figure 4: A print bed of nose-on-chip devices printed on FormLabs Form 2 3D-Printer 21 
Figure 5: Rendering of the transwell mold design ............................................................ 23 
Figure 6: SU-8 50 Posts on silicon wafer (10µm diameter, 35-40µm height), Image 
Obtained by Daniel Sim and Zach Brooks ....................................................................... 24 
Figure 7: Bi-Directional Air Delivery System, Process Flow Chart ................................ 29 
Figure 8: Prototype Bubbler Humidification System and RH & Temperature Sensor 
Circuit ............................................................................................................................... 31 
Figure 9: Picture of the mass flow controller and solenoid valve array ........................... 33 
Figure 10: Picture of the modified Quincy Labs Model 10E Incubator ........................... 34 
Figure 11: Picture of the nose-on-chip device mounted on the incubator sliding wall .... 34 
Figure 12: Rendered model of the nose-on-chip incubator mount ................................... 35 
Figure 13: CFD Simulation of wall shear forces like the anterior region of the nasal 
cavity, Velocity = 5.5 m/s ................................................................................................. 37 
Figure 14: CFD Simulation of wall shear forces like the inferior turbinate of the nasal 




Figure 15: CFD Simulation of wall shear forces like the middle region of the nasal cavity, 
Velocity = 15 m/s .............................................................................................................. 38 
Figure 16: Cell Attachment Site on Transwell Insert ....................................................... 47 
Figure 17: Image of the PDMS membrane showing target features ................................. 53 
Figure 18: Images of membrane thickness. Microwell membrane (left) and through-pore 
membrane (right). ............................................................................................................. 54 
Figure 19: Color density mapping for Stationary cultures (Day 5) cultured on polyester 
membranes and stained using alcian blue ......................................................................... 57 
Figure 20: Color density mapping for Dynamic cultures (Day 5) cultured on polyester 
membranes and stained using alcian blue ......................................................................... 58 
Figure 21: Plot of Mucus production determined by analysis of alcian blue stain ........... 59 
Figure 22: Mucus production data and prediction equations ............................................ 60 
Figure 23: Comparison of stationary and dynamic cultures for 2-hour and 6-hour time 
points ................................................................................................................................. 61 
Figure 24: Two-Way Anova Results for Dark Mucus Production ................................... 63 
Figure 25: Images of β-tubulin (Green) and Actin fibers (Red) for two culture    
conditions .......................................................................................................................... 64 
Figure 26: Velocity Profile and Wall Shear Force Graphs for a channel height of 0.7mm 
modeling the anterior region ............................................................................................. 68 
Figure 27: Velocity Profile and Wall Shear Force Graphs for a channel height of 0.7mm 
modeling the middle turbinate .......................................................................................... 68 
Figure 28: Velocity Profile and Wall Shear Force Graphs for a channel height of 0.7mm 
modeling the inferior turbinate ......................................................................................... 69 
ix 
 
Figure 29: Velocity Profile and Wall Shear Force Graphs for a channel height of 
0.265mm modeling the anterior region ............................................................................. 69 
Figure 30: Velocity Profile and Wall Shear Force Graphs for a channel height of 
0.265mm modeling the middle turbinate .......................................................................... 70 
Figure 31: Velocity Profile and Wall Shear Force Graphs for a channel height of 
0.265mm modeling the inferior turbinate ......................................................................... 70 
Figure 32: Comparison of Simulated WSS values versus calculated WSS values for the 
Anterior Region ................................................................................................................ 71 
Figure 33: Comparison of Simulated WSS values versus calculated WSS values for the 
Middle Turbinate .............................................................................................................. 72 
Figure 34: Comparison of Simulated WSS values versus calculated WSS values for the 
Inferior Turbinate .............................................................................................................. 72 
Figure 35: Diagram of solution positions within the 96 well plate, for the Alcian Blue and 
Fast Red Assay ................................................................................................................ 114 
Figure 36: Diagram of solution positions within the 96 well plate, for the Alcian Blue 
Assay ............................................................................................................................... 117 
Figure 37: Wiring Diagram for the Solenoid Valve Circuit ........................................... 125 
Figure 38: Circuit Diagram for the Solenoid Valve Circuit ........................................... 126 
Figure 39: Arduino Code for the Solenoid Valve Circuit ............................................... 127 
Figure 40: Wiring Diagram for the Humidity and Temperature Circuit ........................ 128 
Figure 41: Circuit Diagram for the Humidity and Temperature Circuit ......................... 129 





LIST OF TABLES 
Table                                                                                                                               Page 
Table 1: Design considerations and importance for the Nose-on-Chip device ................ 16 
Table 2: Design considerations and ranking of importance for the custom transwell 
inserts ................................................................................................................................ 19 
Table 3: Summary of Air Delivery System Goals ............................................................ 29 
Table 4: Optimal inlet velocities to model select nasal regions and comparison of device 
wall shear force to shear force found in the nasal cavity .................................................. 39 
Table 5: Summary of Experimental Trials........................................................................ 48 
Table 6: Membrane Analysis Results ............................................................................... 53 
Table 7: Analysis of density of light and dark mucins produced by RPMI 2650 cells .... 58 
Table 8: Summary of Velocity, Reynold's # and Calculated Wall Shear Stress for 
different channel heights ................................................................................................... 67 
Table 9: Summary of Ansys Discovery Live Simulations................................................ 71 
Table 10: Comparison of Wall Shear Stress Data ............................................................ 73 







LIST OF APPENDICES 
Appendix                                                                                                                        Page 
Appendix A: Protocol for Transwell Support Fabrication ................................................ 77 
Appendix B: Silanization of the Silicon Wafer ................................................................ 81 
Appendix C: Spin Coating of Sacrificial Layer on a Silanized Wafer ............................. 83 
Appendix D: Spin Coating of a Porous Membrane on a Silanized Wafer........................ 86 
Appendix E: Removal of the Porous Membrane (Sacrificial Layer Technique) .............. 89 
Appendix F: Removal of the Porous Membrane (Edge Bead Technique) ....................... 90 
Appendix G: Fabrication of Completed Transwell (Custom Membrane Sample) ........... 92 
Appendix H: Fabrication of Completed Transwell (Commercial Membrane Sample) .... 94 
Appendix I: Plasma Treatment Procedure Using Plasma Etcher...................................... 96 
Appendix J: UV Treatment on Transwell Inserts ............................................................. 98 
Appendix K: Collagen and Poly-L-Lysine (PLL) Treatment Procedure .......................... 99 
Appendix L: Collagen Treatment Procedure .................................................................. 100 
Appendix M: Unfreezing Procedure for Frozen Cell Cultures ....................................... 101 
Appendix N: Changing Cell Culture Media ................................................................... 102 
Appendix O: Passaging Cell Culture .............................................................................. 103 
Appendix P: Freezing Procedure for Cells ..................................................................... 105
xii 
 
Appendix Q: Procedure for Counting Cells .................................................................... 107 
Appendix R: Procedure for Seeding Cells on Transwell Membranes ............................ 108 
Appendix S: Cytoskeleton Immunocytochemistry Procedure ........................................ 110 
Appendix T: Alcian Blue and Nuclear Fast Red Procedure: .......................................... 113 
Appendix U: Alcian Blue Assay Procedure: .................................................................. 116 
Appendix V: Membrane Porosity Analysis on ImageJ................................................... 119 
Appendix W: Alcian Blue Color Density Mapping Procedure ...................................... 120 
Appendix X: Alcian Blue Mucus Quantification Procedure .......................................... 121 
Appendix Y: Photolithography Procedure for Wafer Development ............................... 122 
Appendix Z: Bi-Directional Air Delivery System Operational Protocol........................ 123 
Appendix AA: Bi-Directional Air Delivery System, Solenoid Valve Circuit and Arduino 
Code ................................................................................................................................ 125 
Appendix AB: Humidity and Temperature Monitoring System, Circuit and Arduino  











This research was funded through a fellowship grant with Defense Associated 
Graduate Student Innovators (DAGSI). I would like to thank DAGSI for providing this 
opportunity to further my learning. 
I would like to thank the following individuals for their support and expertise:  
Dr. Saber Hussain, for his mentorship, sponsoring this research and sharing lab resources; 
Dr. Angela Dixon, for her research advising and mentorship; Dr. Tarun Goswami, for his 
support and guidance; Dr. Steve Kim, for sharing lab resources; Dr. Daniel Sim and 
Richard Johnston, for assistance with photolithography procedures; David Mohl, for 
providing consultation on building air flow pumping systems; Dr. Mike Brothers, for 
sharing lab equipment and flow meters; Dr. Casey Pirnstill, for sharing his 3D-printing 
equipment; WBI MakerHub associates Logan Rowland, Tom Mitchell, and Joe Althaus, 
for their assistance with 3D-printing; AFRL Legacy Program for sharing 3D-printing 
equipment; and Micah Jordan, for her assistance with cell culturing. 
Thank you to my family, who have been there to support and encourage me 
throughout this endeavor.  
Most importantly, thank you Alannah for your unwavering love and encouragement. I 




1.1   Motivation for Research 
The main objective of this research is to develop a microfluidic device that 
models flow within the nasal cavity to investigate how air flow-induced mechanical 
stresses effect mucus secretion and cytoskeletal structure of the nasal epithelium. 
Specifically, this research will seek to answer the question of: do airflow-induced wall 
shear stresses (WSS) and wall shear forces (WSF) affect the amount of mucus produced 
by the nasal mucosa? This investigation can seek to determine the effectiveness of a 
dynamic airflow system on air-liquid-interface cultures compared to traditional static 
culture conditions. The hypothesis is that airflow induced WSS and WSF on the nasal 
mucosa will influence mucus production, and effect cytoskeletal remodeling. 
1.2   Impact of toxins on upper respiratory system 
Airborne particulates have always been present in the atmosphere, though these 
particles have evolved from organic materials such as pollen or plant fragments to a large 
variety of particles containing metals and chemicals (1). Most of the nanoparticles in 
urban areas are created from the partial combustion of fossil fuels (1).  In addition to 
particles, there are also other hazards such as harmful gases like toluene or carbon 
monoxide. As industrial society continues to evolve, these particulates and environmental 
hazards will become increasingly prevalent. The wide variety of environmental hazards 
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are a large threat to human health, as the effects of many of the pollutants may not be 
fully understood. There are multiple avenues that particles can use to enter the body once 
in the respiratory system. In the upper respiratory system Airborne particulates pose the 
largest risk to the respiratory system, as the air-blood barrier has a high permeability, 
which results in fast uptake of particles (2). 
1.3   Environmental threats to airmen and civilians 
The dangers of airborne particulates and environmental pollutants are of interest 
to airmen and the Armed Forces. These individuals will be placed in a large array of 
scenarios with limitless combinations of potential airborne hazards. For example, a 
highly used substance that has very real consequences to air pollution and respiratory 
health is diesel exhaust. Diesel exhaust has over 40 constituents that have been proven to 
be toxic and include several of the particulates such as multiple heavy metals, and a 
variety of carbonaceous materials (1). If airmen are stationed in overseas countries with 
less fuel regulations that the United States, there is an increased risk of exposure to diesel 
exhaust pollution. The Air Force, as well as other organizations, have shifted their fuel 
usage away from diesel exhaust in vehicles, leaning more towards JP-8: a kerosene-based 
jet fuel. While this jet fuel does not have as many harmful constituents as diesel fuel, it 
has its own inherent dangers. JP-8 is the most common source of chemical exposure in 
the Air Force, particularly effecting flight and ground crews as they perform operations 
and maintenance on aircraft (3). Due to the long lifetime of JP-8, personnel will often be 
exposed on their skin or clothing, which causes a prolonged exposure to the hazard, as 
they continuously breathe in vapor and particles from the spill. Previous iterations of this 
line of jet fuel were much more volatile, which lessened exposure times compared to JP-
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8. JP-8 can be especially dangerous to the respiratory tract, and by extension, the nervous 
system. Exposure to the fuel has been linked to a variety of issues such as auditory 
brainstem dysfunctions, asthma, running/stuffed nose, and gait disturbances (3, 4). In 
2018, the Air Force spent an estimated 81% of their total energy budget on JP-8 fuel and 
are expected to continue its usage until at least 2025 (5).  
Military personnel are also exposed to firearms and munitions more frequently 
than most individuals. When firearms are used, they can disperse many particles, one of 
the most dangerous being lead, becoming airborne from either the primer ignition or 
bullet fragments during trajectory. These particles become especially dangerous when 
firearms are used in enclosed quarters, such as indoor firing ranges, as it is more difficult 
for the particles to disperse. In these scenarios, the particles have a greater chance of 
being inhaled and will often linger on clothes or skin. These persistent particles become a 
hazard for other individuals who encounter the affected person, as they can become 
airborne in their vicinity. Persistent lead exposure can lead to increased levels of lead in 
the blood. Increasing the blood lead content above the recommended threshold of 5µg/dL 
can lead to a decrease in hearing efficiency and kidney disorders. A 2017 review of 
nearly 36 firing range studies discovered that most of the participants in each study had a 
blood lead content greater than 5µg/dL, showing this to be a prevalent issue (6). In 
warzone scenarios, military personnel may also be exposed to shrapnel from additional 
sources, such as explosive ordinance or environmental debris, providing increased 
avenues to dangerous particles or respiratory hazards. 
During a fire, harmful smoke and carbon monoxide are emitted which can be 
detrimental to the respiratory system. In enclosed conditions, these threats can pose an 
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immediate danger, as they can disable an individual, or greatly reduce their ability to 
escape the fire. In first responders, such as emergence medical technicians or firemen, 
prolonged and chronic exposure to these hazards are expected, leading to an increased 
risk of respiratory illnesses. A carbon monoxide concentration of only 1% is a serious 
health threat, as carbon monoxide is rapidly absorbed by pulmonary epithelium and has a 
much greater attraction for hemoglobin than oxygen (7, 8). 
1.4   Nasal Mucosa Background 
1.4.1  Purpose of mucus membrane/mucus production 
The nasal mucosa plays a vital role in protecting the body from inhaled particles 
(9). Mucus produced by the nasal mucosa acts as the first line of defense to foreign 
matter entering the body through the respiratory system. Mucus is secreted by multiple 
cells found in the nasal mucosa in response to different biological stimuli, ranging from 
oxidants to biophysical changes.  The mucus forms a barrier on the surface of the mucosa 
which is then used to stop and accumulate inhaled particles (9). Once particles are 
trapped, mucociliary clearance directs the matter out of the nose to prevent the particles 
from entering the body. In this mucociliary mechanism, cilia located on the surface of the 
nasal epithelium beat in a synchronized pattern to slowly move mucus out of the nasal 
cavity. 
There are multiple routes in which inhaled particulates can travel once they enter 
the nasal cavity. Most of these pathways are influenced by the size of the particles, 
ranging from nanoparticles to microparticles. The nasal cavity can clear 95% of liquid 
aerosols and particles greater than 15 micrometers in diameter (10). 
5 
 
 In situations where particles are smaller than 15 micrometers, they can be 
absorbed by the nasal mucosa and ultimately enter the blood stream. These particles can 
clear the nasal mucosa and enter through the junctions of the nasal epithelium. Particles 
larger than 15 micrometers are typically stopped by the mucus layer and are moved to be 
ejected from the body. In some instances, these particles could be absorbed through the 
digestive system. 
Particles that travel to the olfactory region can navigate through the epithelium 
and enter the brain through the olfactory pathway. It is estimated that roughly 1% of all 
inhaled particles between 1-2nm in size deposit in the olfactory region (11). These 
nanoparticles can then travel along the olfactory bulb to reach the brain, allowing the 
particles to bypass the blood brain barrier, and gain easier entrance to the brain. Research 
indicates that this route may be a strong contributor to neurodegenerative diseases such as 
Alzheimer’s or Parkinson’s (11). Since this pathway is effective to use to access the 
brain, it has become a popular avenue of exploration for drug delivery. In this intranasal 
nose-to-brain delivery model, the drug is encapsulated in a particle and inhaled as an 
aerosol. The carrier is investigated to ensure that it can bypass the nasal mucus and 
mucociliary clearance system. 
Particles smaller than 2-5µm can bypass the nasal defense and deposit on the 
surface of the lungs. These particles avoid entrapment by the nasal mucus and navigate 
through the upper respiratory system, reaching the lower respiratory system where they 
are ultimately deposited on a surface. The lungs feature a very permeable membrane that 
can enable these particles to quickly enter the blood stream (12). This is ideal for inhaled 
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drug delivery applications; however, it represents a weak point for potentially harmful 
inhaled particles.  
1.4.2 Structure of nasal mucosa: Cells and Proteins 
The nasal cavity consists of several different regions, each with distinctive cell 
types. The nasal cavity regions have been explored extensively, and a diagram is in 
Figure 1 (13). 
 
Figure 1: Diagram of the Nasal Cavity Regions (13) 
The critical regions of interest for this research are the squamous, respiratory, 
transitional and olfactory mucosa. These regions produce mucus as a defense and 
functional mechanism, described previously. The squamous mucosa is in the anterior 
region of the nose, containing stratified epithelium, hairs, and sebaceous and sweat 
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glands (13). The transitional mucosa lies on the borders of the other regions and has the 
same features as the squamous epithelium but does not contain cilia. The olfactory region 
harbors neuronal cells that are responsible for the detection of odors in inhaled air (13). 
The olfactory mucosa contains olfactory neurons, basal stem cells, and bowman’s glands, 
which produce and secrete mucus in this region. The respiratory mucosa entails the 
largest area of the nasal cavity, including the turbinate regions. The turbinate regions are 
structured to have an increased surface area and are responsible for conditioning inhaled 
air. The respiratory mucosa contains mucus cells, ciliated and non-ciliated columnar 
cells, cuboidal cells, and basal cells (14). 
The epithelial cytoskeleton plays an important role in paracellular permeability. 
Actin fibers are close in contact to tight junctions, which limit diffusion of certain 
molecules. It has been discovered that when actin fibers are disrupted, it can alter tight 
junction strands. This disruption can change permeability, allowing different molecules to 
pass (15). Β-tubulin fibers are also critical to the epithelial cytoskeleton, as they are 
responsible for contributing to its structure by way of microtubules. In the nasal mucosa, 
the epithelial cytoskeleton acts as a barrier, where the tight junctions regulate particle 
intake. Damage to the epithelial cytoskeleton can cause an increase in particle uptake or 
create new routes in which particles could travel through the epithelium. 
1.4.3 Airflow Characteristics in Different Nasal Regions 
Proper airflow is critical for maintaining physiological functions in the nose, such as 
filtering and conditioning of inhaled air (16). The architecture of the nose is crucial to 
determining airflow patterns (16). There can be extreme variations in flow characteristics 
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for different individuals with differing nasal structure. In-silico models have been used to 
investigate the airflow dynamics within the nasal cavity. 
In silico models are computer simulations of real-world experiments. In silico models 
can be used to gain insight in how a process works, or to assess the performance of a 
device before it is built. In silico models vary in complexity, and can range from single 
path models, to complex multi path models (2). In silico models are commonly used to 
simulate microfluidic devices before they are built, in order to gauge their effectiveness 
(17). The nasal cavity is a complex structure, with various regions that each have their 
own flow characteristics, making computational fluid dynamics a requirement to assess 
the flow patterns within the cavity. 
In a study by Zhao et al. the nasal structures of 22 participants were recreated in a 
CFD program using a CT image of the nose. Modeling was then performed to determine 
differences and similarities in nasal flow characteristics. The study discovered that peak 
airflow occurred in different locations for different individuals. For example, the peak 
airflow appeared in either the inferior meatus, middle meatus, or lower and upper 
common meatus (16). The middle region of the nasal cavity commonly achieved more 
airflow than the other regions. During the simulations, if there was increased flow to one 
region, there would be decreased flow to other regions in the same model. The study 
found that different flow types (laminar or turbulent) produced nearly identical velocity 
profiles and nasal resistances. The study concluded that turbulent airflow in the nasal 
cavity has the potential to increase mixing of air and affect nasal function (16). However, 
during relaxed breathing (<200 ml/s), nasal airflow is dominated by laminar flow, while 
having some transitional flow (18, 9). In order to generate turbulent flow, strong sniffing 
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must occur, although even then it is likely that flow will not be entirely turbulent, as 
suggested by ratios of turbulent viscosity to molecular viscosity (12). These results show 
that there are minor differences between turbulent and laminar flow models, and that 
airflow distribution is predominantly located in the middle region of the nasal cavity. 
1.4.4 How shear stress effects nasal mucosa 
As reported in a study by Even-Tzur, N. et al., wall shear stresses (WSS) can have 
numerous effects on the nose. The study showed that for higher wall shear stress values, 
there was an increase in the fragmentation of cytoskeletal fibers, specifically β-tubulin 
fibers (9). In addition, it was discovered that while increases in wall shear stress values 
did have some influence on mucus production, higher durations of WSS exposure had a 
much larger impact. For higher durations of exposure, there were higher levels of mucus 
production (9). The results of the study imply that wall shear stresses induced by steady 
unidirectional flow have a strong impact on the structure and function of nasal tissue. 
Immediately after removal of the WSS, the β-tubulin fibers showed a decrease in 
integrity. The cells were investigated 24-hours after removal of the WSS, and it was 
discovered that the B-tubulin fibers had almost entirely recovered (9). This discovery 
implies that once the external stressor is removed, the fibers repair and remodel 
themselves to fit the structure typically seen in stationary cultures. This shows the 
possibility of cell restructuring in response to WSS, which could create new pathways or 
allow altered chemical and physical interactions with the nasal tissue (9). 
The influence of WSS and WSF on the nasal mucosa is important to investigate. 
If WSS influences the formation of new transport pathways or facilitates different 
interactions, then it could play a significant role in altering particle uptake by enhancing 
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particle transport (9). This is an important toxicology assessment, as the nose is 
responsible for protecting the rest of the respiratory tract from inhalation of rogue 
particles, and the affect flow induced WSS may have on nasal tissue could compromise 
its duties. 
1.5 RPMI 2650 Cell Line 
RPMI 2650 is a human nasal cell line. It was first isolated from a squamous cell 
carcinoma of the nasal septum (19). RPMI 2650 is the primary human nasal cell line used 
in experiments modeling the nasal cavity. It is preferred as a non-invasive method to 
assess drug delivery due to its easy maintenance and reproducibility of results (19). The 
cells have consistent growth rates and can reach confluency within a short time frame. It 
is often preferred over excised nasal tissue, as it is much less expensive and easier to 
maintain. Researchers have shown that the cells form tight junctions, with transepithelial 
electrical resistance (TEER) like that of the nasal mucosa and can also secrete a 
homogenous coating of mucus on the cell surface (20). The RPMI 2650 cells do not 
contain cilia, so they are unable to utilize the mucociliary clearance system, though they 
are a promising candidate for drug delivery trials (21). 
There has been some controversy surrounding the RPMI 2650 cells, and whether 
they are a valid model of the nasal mucosa. This controversy primarily stems from the 
effect of different culturing conditions on the cells. Despite these concerns, there are a 
plethora of studies that have been conducted to further optimize the cells as a nasal model 
(19, 20, 21). The studies seek to determine the optimal culture conditions to ensure that 
the cell characteristics are reproducible at ALI conditions. 
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1.6 Dish culture models 
Some of the current models for evaluating toxicity involve dish culture models 
(22). These models are designed to use cell cultures that mimic tissues and organs (22). 
While dish cultures are useful models, they do have drawbacks that require addressing. 
1.6.1 Pros 
There are several advantages of using dish culture models, as opposed to other 
alternatives. The main advantage is that the dish culture model is much simpler to 
administer. Using a dish culture does not bring the same ethical or economic concerns as 
animal trials. Additionally, scientists do not need to be concerned regarding cross-species 
correlation (2). Due to the nature of dish culture models, they have a lower complexity, 
which decreases the difficulty of conducting the experiments compared to models such as 
animal trials. 
1.6.2 Cons 
Despite these models typically being simpler than animal trials, they do come 
equipped with several drawbacks, such as failing to retain functions related to the tissue 
types, and inability to represent the structural or mechanical features imperative to organ 
function (22). These cell culture models are typically limited to a static environment. 
With traditional dish culture test set-ups, the cells are exposed to compounds that are 
suspended in medium (2). In real world scenarios, the physiological environment of the 
cells is that they are supplied nutrients from the basal side, while the apical side interacts 




1.7 The Need for Microfluidics  
Microfluidics play an important role in research and are uniquely poised for use in 
toxicology assessments. Microfluidics exist as the perfect in-between of dish cultures and 
animal trials. They are inexpensive compared to animal trials, but are still relatively easy 
to conduct experiments, like the dish cultures. Essentially, microfluidics combines the 
benefits of dish cultures and dynamic functionality on a microscale, allowing results to be 
more transferrable to in-vitro scenarios. These benefits give researchers the ability to 
conduct biologically accurate toxicological assessments without ethical concerns, 
financial limitations, or large time requirements. 
 Current methods of assessing nanoparticle toxicity involve extensive animal or 
human trials. By developing a microfluidic device capable of assessing toxicity to the 
nasal mucosa these outdated methods will no longer be needed. Lack of experimental 
models creates a significant difficulty in evaluating toxins (22). Most toxicology tests are 
currently performed using animal studies, which can be slow, costly, and potentially 
unethical (22). Dish cultures are used for many toxicity tests, such as cytotoxicity 
screening (2). Unfortunately, these culture models do not appropriately reproduce the 
dynamic environment the cells exist in the human body. Microfluidic devices are 
replacing such tests, as they can provide a more accurate environment, which has created 
a surge in the field (17). The microfluidic assessments are much less expensive and much 





1.8 Microfluidics Models of the Respiratory System 
Microfluidic devices are small models that allow manipulation of fluids through the 
geometry of the device and flow settings. These devices are commonly used with cell 
cultures, as they enable precise control of various conditions to perform assessments on 
the cultures. Labs-on-chip or organ-on-chip are a subset of microfluidics that are 
designed to mimic regions of the body using a cell culture integrated into the device. 
These on-chip devices can be used for many different studies where mimicking certain 
organs or body regions are beneficial or necessary. 
1.9 Benefit of Microfluidic Devices  
With microfluidic devices, the physiological environment of tissues and organs 
can be mimicked, creating a more accurate representation of the biological model. 
Another major advantage of microfluidics is the capability to investigate cell cultures in 
an environment that allows for dynamic and mechanical stimulation. This combination 
allows for an in vitro model that is much more transferrable to in vivo application. 
Microfluidic devices are commonly created using fast fabrication techniques, and 
polymer materials are usually selected for the build to decrease development cost and 
time (17). The efficiency of microfluidic development allows it to effectively compete 
with other dynamic models. One of the biggest advantages to microfluidic devices is the 
ability to create simulations which will accurately predict device performance. By using 
“numerical prototyping” or computational modeling, the number of physical prototypes 
required to perfect a design can be drastically reduced (17). Using computational 




Microfluidic models currently exist for the upper and lower respiratory system. 
Each model is designed with a specific purpose in mind. One such model is a hybrid 
device which utilizes an integrated circuit with olfactory sensory neuron cells (23). Other 
models have been developed for airflow simulation, the investigation of cilia production 









2. MATERIALS AND METHODS 
2.1    Overview 
 To investigate the effect of wall shear stresses on RPMI 2650 cells, an 
experimental platform was required. This platform consisted of an air delivery system, an 
on-chip device, and custom transwell units. The components of the system interfaced 
together to allow for reproducible experiments to take place. 
2.2   Nose-On-Chip Device and Transwell Inserts 
2.2.1 Device Overview 
 A nose-on-chip device was designed using CAD software (AutoDesk Inventor). 
The chip was designed to be incorporated into an air delivery system and integrate with 
custom transwell inserts. It drew upon principles of microfluidics and lab-on-chip devices 
to serve as an experimental platform to mimic the nasal cavity. The device was required 
to fulfill several important requirements to be successful. The design requirements are 






Table 1: Design considerations and importance for the Nose-on-Chip device 
Design Considerations and Ranking 
Ranking of Importance                    
1 = low importance                             
5 = High Importance 
Nose-On-Chip device 1 2 3 4 5 
Ability to be 3D-printed 
    
X 
Compatibility with custom transwell inserts 
    
X 
Novel transwell integration 
    
X 
Cost Effective to Manufacture 
   
X 
 
Cell culture compatibility 
    
X 
Compatibility with air delivery system 
    
X 
Easy to change media in transwell inserts 
   
X 
 
Barbed nozzles integrated into device 
 
X 
   
Multiple slots for inserts (>2 per run) 
   
X 
 
Capacity to support ALI 
    
X 
Device cultures can be maintained in device  
   
X 
 
Generation of wall shear forces 
    
X 
Generation of wall shear stresses 
    
X 
Model multiple nasal regions 
    
X 
 
2.2.2 Device Components 
The nose-on-chip device (Figure 2) was 74mm long, 20mm wide, and 20mm tall 
when fully assembled. The device consisted of five main parts: the microchip base, the 




Figure 2: Overview of the Nose-on-Chip device components 
The macrochip base (36mm long, 20mm wide, and 14mm tall) was comprised of 
an airflow channel, cylindrical openings to house custom transwells, a groove around the 
top, and a bottom that stabilizes the device when in use. The groove at the top slotted into 
the lip of the lid.  
The lid (36mm long, 20mm wide, and 8mm tall) aligned with the groove on the 
microchip base, allowing it to be easily removed and placed on the device. The lid was 
designed to prevent contaminants from entering the insert chambers or inserts while the 
device was in use. 
The insert chambers were each designed to house a custom transwell insert. There 
were three insert chambers in the device, each chamber was 6mm in diameter and 6mm 
tall. The bottom of the insert chamber was aligned and open to the top of the flow 
channel, which then connected to the barbed flow nozzles at both ends. 
The barbed flow nozzles (2, one at each end, 19mm in length) were integrated 
into the device, featuring three barbs. The outer diameter of each barb was 9.5mm at the 
widest point and 8mm at the smallest, compatible with L/S 18 tubing. Using barbed 
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nozzles, the device could be easily hooked up or disconnected from the airflow system. 
The barbs had an inner channel with a diameter of 4mm, which lofted into the rectangular 
shape of the airflow channel. 
The airflow channel (36mm long, 6.25mm wide, and 4mm tall) was rectangular 
and integrated into the microchip base. The channel was continuous lengthwise through 
the entire device, and the top of the channel intersected with the basal side of the 
transwell inserts. 
The custom transwell inserts (9mm tall, 8mm wide at the top, and 6mm wide at 
the bottom) were inserted into the insert chambers and held in place by the outer rim that 
rested on the top of the macrochip base. The inserts were comparable in size to 
commercially available 96-well transwells. The inserts consisted of two major 
components, the transwell support (Figure 3) and the membrane which was attached to 
the bottom of the support. The design requirements for the custom transwell inserts are 




Figure 3: 3D model of the custom transwell support 
 
Table 2: Design considerations and ranking of importance for the custom transwell inserts 
Design Considerations and Ranking 
Ranking of Importance                    
1 = low importance                             
5 = High Importance 
Custom Transwell Inserts 1 2 3 4 5 
Cell culture compatibility 
    
X 




Mass producible using molds 
   
X 
 
Custom membrane integration 
   
X 
 
Compatibility with commercial membranes 
   
X 
 
Cell seeding on basal side of membrane 
    
X 
Capability to be inverted (insert rests on top) 
   
X 
 
Ease of imaging while cultures are growing 
   
X 
 
Inexpensive to mass produce 
   
X 
 
Convenient to image and stain after 
experiments 
    
X 
Membrane is removable from support 








 Nose-on-Chip Device Fabrication 
 The nose-on-chip device was fabricated using a FormLabs Form 2 3D printer. 
FormLabs clear resin was chosen for the device material, however other resin types could 
also be used. Clear resin presented good overall mechanical properties, while also having 
optical properties that allowed the airflow channel and insert chambers to be visible 
through the semi-transparent outer walls of the device. This allowed for convenient 
monitoring of any leaks in the transwell inserts while they were functioning in the device. 
 Fabricating the device using 3D-printing allowed multiple devices to be 
manufactured at the same time (Figure 4), the maximum of which was dependent on the 




Figure 4: A print bed of nose-on-chip devices printed on FormLabs Form 2 3D-Printer 
Each device used less than 30mL of resin, including supports and rafts, which 
allowed a single device to be created for less than $5.00 in material cost. Each device was 
reusable many times, so additional devices were only required to maintain multiple 






 Transwell Insert Fabrication 
2.2.3.2.1 Transwell Supports 
The transwell supports were cast six at a time from a 3D printed resin mold that 
consisted of eight parts: two shells and six stoppers. The mold is a cuboid (25mm tall, 
50mm wide and 50mm long, Figure 5) that contained 6 negative cutouts for transwell 
supports, each with two fill/drain ports at the top of the mold. The mold was held together 
by three 55 mm M3 bolts and three M3 nuts. Polydimethylsiloxane (PDMS) was used at 
a 10:1 ratio of elastomer base to curing agent to fabricate the transwell supports. The 
PDMS was mixed and degassed, then applied to a constructed mold using a 1mL syringe. 
The PDMS was filled through the fill port, until it began to leak out of the drain port at 
the opposite side of the stopper. This ensured that the PDMS adequately filled the 
entirety of each mold crevice. Immediately after, the filled mold was placed in a 60°C 
oven for 3 hours to cure. Once cured, the mold was taken apart and excess PDMS was 
carved from each support using a scalpel. The finished supports were stored in a covered 
container until the membrane application was ready. Approximately 10g of PDMS was 




Figure 5: Rendering of the transwell mold design 
2.2.3.2.2 Transwell Membranes 
The transwell inserts were created with custom developed PDMS membranes, or 
with commercially available membranes. The custom membranes were useful in creating 
through-pore or microwell membranes with a pore size of 10µm. The commercially 
available membranes allowed for pore sizes smaller than 10µm. 
To create the custom membranes, a photomask film was developed that contained 
a hexagonal array of 10µm circles, with an interpore spacing of 10µm. The array was 
first designed in CAD software then populated to fill the entire area of a 4” circle using 
2D plotter software (CAMMaster). The design was then printed on to a transparent 
photo-film mask (Kodak film) using a high-resolution plotter printer (FineLine Imaging). 
Photolithography techniques were employed using the photo-film mask with 4” silicon 
wafers coated with SU-8 50 photoresist to create a hexagonal array of posts (10µm in 
diameter, 35-40µm in height, spacing of 10µm, Figure 6) that acted as the mold for the 
membranes. The silicon wafer molds were then treated with silane or spin-coated with a 
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sacrificial layer of dextran. PDMS, mixed at a 10:1 ratio, was spin-coated on the wafer 
and then immediately cured to create the custom membranes. The membrane thickness 
and through-pore parameters were controlled based on the spin coater settings. Curing the 
membrane immediately after spin-coating was critical for through-pore membranes, as 
the PDMS tended to create a film over the top of posts if not cured in an adequate time 
frame. This method was successful in creating both through-pore membranes, as well as 
microwell membranes. The microwell membranes contained pores that did not travel 
through the thickness of the membrane. 
 
Figure 6: SU-8 50 Posts on silicon wafer (10µm diameter, 35-40µm height), Image Obtained by Daniel Sim and Zach 
Brooks 
Once the spin-coated membranes were cured, the membrane was removed from 
the wafer surface. If a sacrificial layer was not used, an edge bead of PDMS was painted 
and cured along the perimeter of the membrane surface to allow for easier removal of the 
membrane (25). If a sacrificial layer of dextran was used, the wafer was placed in water 
and heated as needed to dissolve the sacrificial layer and promote membrane detachment 
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(26). In both methods, forceps were used to aid in the removal of the membrane from the 
wafer surface. 
Once the membrane was removed, it was placed flat on a clean cutting board 
surface. Any overlapping segments of the membrane were unraveled and flattened. A 
5mm biopsy punch (Acuderm P525) was used to create 5mm cut-outs of the membrane. 
These membrane samples were then placed in a covered container until ready to be 
attached to the supports. 
In instances where a smaller pore size was desired, commercial membranes were 
also used. The polyester membranes featured 0.4µm pores and were isolated from 
transwells (Costar 3460-clear, 12mm diameter) using a #11 scalpel to peel the membrane 
off the commercial support. Once the membranes were peeled, a 5mm biopsy punch was 
used to create cut-outs of the membrane. Each 12mm membrane sample created two 
5mm cut-outs. These membrane samples were then placed in a covered container to 
protect them from dust and other contaminants until ready to be attached to the supports. 
This procedure could be replicated with any commercially available transwell or stand-
alone membrane to create 5mm membrane samples to be used for transwell fabrication. 
2.2.3.2.3 Completed Transwell Insert 
 Transwell inserts were created with either PDMS or polyester porous membranes. 
PDMS prepolymer (10:1 ratio) was used to fuse the membrane onto the support structure. 
For the custom PDMS membrane samples, this created a permanent bond between the 
support and membrane. For the polyester membrane samples, this bond was strong 
enough to hold the membrane in place and prevent leakage, however when it needed to 
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be removed, the bond was cleanly broken by sliding a scalpel between the membrane and 
support. This preserved the entire membrane sample for imaging and analysis after 
experiments were conducted. 
 The procedure began with fresh PDMS (10:1 ratio) which was mixed and 
degassed. The stirring stick was then used to isolate a small amount of PDMS which was 
flattened so only a thin layer of PDMs was on the end. A transwell support sample was 
retrieved using forceps, and gently stamped into the thin layer of PDMS. Any excess 
PDMS that filled the interior of the insert was wiped away with a second pair of forceps. 
The support was then inverted and placed on a glass microscope slide. A 5mm membrane 
sample was retrieved using forceps and carefully placed on the center of the support, so 
that there were no gaps. The outer rim of the membrane was gently pressed to ensure its 
contact with the fresh PDMS layer, and that there were no gaps. Once all inserts were 
prepared, they were immediately taken to the 60°C oven and cured for 2 hours. Upon 
removal, the completed inserts were stored in a sealed container until needed for 
experiments. 
 Device Operation 
Prior to operation, the device was submerged in 70% ethanol for 30 seconds, then 
submerged in distilled water for 30 seconds, and placed in a sterile petri dish within a 
culture hood to dry. A sterile gauze sponge (Kendall Curity) was used to wipe any excess 
liquid from the device as needed. The device was left to dry for at least 30 minutes prior 
to the addition of the seeded inserts. 
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The transwell inserts followed a different sterilization process depending on 
which membrane was used. The protocol varied as each membrane had different 
properties and the bond between the support and membrane differed based on membrane 
material. 
 For the custom PDMS membrane-based inserts, the insert was submerged in 70% 
ethanol for 3 minutes, then submerged in distilled water for 3 minutes, and placed in a 
sterile petri dish within a culture hood to dry. A sterile gauze sponge was used to wipe 
any excess liquid from the device as needed. Once the insert was dry, it was taken to a 
plasma chamber and plasma treated following the protocol in Appendix I. Following the 
plasma treatment, the insert was submerged in distilled water and treated with UV light 
for 1 hour. The insert was dried, and the basal surface of the membrane was coated with 
collagen (320µg/mL) and poly-l-lysine (320µg/mL) and treated overnight. The surface 
was washed once with PBS and any excess wicked from the surface using a sterile gauze 
patch. RPMI 2650 cells were seeded onto the basal side of the membrane following the 
protocol in Appendix R. 
The polyester membrane-based inserts were UV treated for 1 hour. Afterward, the 
surface of the membrane was coated with collagen (320µg/mL) and treated overnight. 
The surface was washed once with PBS and any excess wicked from the surface using a 
sterile gauze patch. RPMI 2650 cells were seeded onto the basal side of the membrane 
following the protocol in Appendix R. 
Once both the device and inserts were prepared, the device was loaded with the 
seeded inserts. The device was placed within a sterile petri dish and moved to an 
incubator (37°C and 5% CO2) where it would remain until the cells reach confluency and 
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were ready for experiments. The media was changed at two-day increments, during 
which the device was transported to the culture hood where the lid was briefly removed 
allowing access to the apical compartment of the custom inserts. Old media was removed 
by pipette and new media was added following the protocol in Appendix N. The device 
was replaced in the incubator. To monitor cell growth, media was removed from the 
inserts of interest, and the inserts placed in a 96-well plate. The rim of each insert held it 
in place, elevating the basal side of the membrane above the bottom of each well so the 
cultures were undisturbed. The cultures were imaged, then replaced in the device and 
refilled with media. 
2.3 Bi-Directional Air Delivery System 
A bi-directional air delivery system was developed to simulate a square wave 
breathing cycle. A process flow diagram for the air delivery system can be found in 
Figure 7. All the components were designed to work together to mimic nasal breathing 
under controlled conditions. This system differed from other commonly used systems, as 
it allowed fresh airflow to impact the cells in two directions. A major goal for the air 
delivery system was to create a modular system that contained all the components 
necessary to perform a wide variety of airflow experiments. The other goals for the air 




Figure 7: Bi-Directional Air Delivery System, Process Flow Chart 
 
Table 3: Summary of Air Delivery System Goals 
Design Considerations and Ranking 
Ranking of Importance                    
1 = low importance                             
5 = High Importance 
Airflow Delivery System 1 2 3 4 5 
Controllable flow rate     X 
Flow rate readout display for monitoring    X  
Controllable humidity and airflow temperature     X 
Temperature /humidity readout display for monitoring    X  
Temperature control for cell culture     X 
Bi-Directional air flow     X 
Controllable breathing pattern     X 
Breathing pattern mimicking human breathing    X  
Simple to change breathing pattern   X   
Ability to mount/fix device within incubator    X  
Quick change device in or out of system     X 
Gas mixture flexibility    X  
Compatibility to add aerosol generation    X  





2.3.1 Air Delivery System Components 
The air delivery system consisted of seven major parts: the gas cylinder, the 
humidification system, the mass flow controller, the solenoid valve array, the incubator, 
the cell interface device, and the fume hood.  
The system derived its air source from a gas cylinder placed at the beginning of 
the system. The gas source used in this research was a 95% air, 5% carbon dioxide 
mixture (AirGas # X02AI95C2000117). The carbon dioxide was included as the 
incubator paired to the air delivery system did not have a CO2 function. This gas source 
could be altered to simulate different air conditions. For example, carbon monoxide could 
be included in the air mixture at select concentrations to evaluate its effects on the RPMI 
2650 cultures. A single stage CGA 590 regulator (Harris 25GX-145) was attached to the 
gas cylinder to drop the pressure down to a level suitable for the system. 
The humidification system (Figure 8) contained three bubbler chambers (Salter 
Labs) placed in series. The first bubbler chamber was responsible for humidification of 
the incoming air. It was filled to specified levels with distilled water. The chamber was 
placed on a hot plate to control the temperature of the water. By changing the fill-level of 
the chamber and the temperature of the water, desired temperature and humidity levels of 
the airflow were established. For the experiments conducted in this research, the chamber 
was filled with 90 mL of water and the hot plate was not used. The second bubbler 
chamber was used to remove any large droplets of water or condensation from the air 
flow before it continued to more sensitive pieces of equipment. The third bubbler 
chamber was modified to house a temperature and RH sensor (AM2302) paired to an 
Arduino UNO. The Arduino and circuit were mounted inside a waterproof junction box 
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(Uxcell, Amazon). The AM302 sensor measured the humidity (0-100%RH ± 2% RH) 
and temperature (-40-100°C ± 0.5°C) of the gas every 2 seconds as it traveled through the 
chamber. The sensor was factory calibrated and verified using a secondary sensor prior to 
use. The bi-directional air delivery system was required to run for an hour for the 
temperature and humidity values of the airflow to stabilize. It was necessary to allow the 
values to settle before experiments were performed, to ensure that there were no 
fluctuations over the duration of the experiment.  
 
Figure 8: Prototype Bubbler Humidification System and RH & Temperature Sensor Circuit 
The mass flow controller was an Alicat MC-10SLPM. The controller was 
programmable for custom gas mixtures, so a single flow controller could be used for 
multiple gas mixtures. The flow controller was responsible for establishing the flow rate 
for the rest of the air delivery system. This was critical, as the wall shear stress applied on 
the cells was governed by the flow rate, since all other factors remain constant. The mass 
flow controller regulated the volumetric or mass flow rates, at rates ranging from 0-10 
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SLPM. The flow controller was professionally calibrated prior to use. A backflow 
preventer was placed immediately after the flow controller, to prevent any potential 
backflow from damaging the equipment. 
The solenoid valve array was responsible for regulating the square wave breathing 
pattern. The square wave breathing cycle consisted of an inhalation, exhalation, and 
resting phase. The array consisted of five solenoid valves (Yosoo 12V 1/4inch 2 Way 
Valve) which would open or close in response to a voltage signal from the Arduino 
controller. The valves were normally at a closed position, which prevented fluid from 
passing, and the Arduino was programmed to open specific valves at certain times in the 
cycle to allow flow through the system in the desired direction. During the inhalation 
phase, valves 1 and 3 opened, which allowed flow through the device and out of the 
system. During the exhalation phase, valves 2 and 4 opened, which allowed flow through 
the device in the opposite direction, and out of the system. During the resting phase, 
valve 5 opened, which allowed flow to bypass the device and exit the system. A diagram 
of the solenoid valve array can be found below in Figure 9. The circuit diagram and 
Arduino code can be found in Appendix AA. The Arduino and circuit were mounted 
inside a waterproof junction box (Uxcell, Amazon).  After the air flow passed through the 





Figure 9: Picture of the mass flow controller and solenoid valve array 
The incubator (Quincy Lab, Model 10E, Figure 10) was customized to feature 
three sliding walls that were used to mount various microfluidic components. The 
incubator functioned solely to house the nose-on-chip device in a temperature regulated 
environment of 37°C. On the rear of the incubator were six barbed nozzles (two for each 




Figure 10: Picture of the modified Quincy Labs Model 10E Incubator 
The nose-on-chip device was housed within the incubator (Figure 11). A custom 
mount (Figure 12) was developed to situate the nose-on-chip devices on the sliding wall. 
The custom mount also held the tubing in place so that the device was easily integrated 
into the air flow system. This was useful, as it allowed for easy replacement of the device 
when one experimental run ended, and another began. 
 





Figure 12: Rendered model of the nose-on-chip incubator mount 
Finally, a fume hood was used to contain the exhaust from the air delivery system. 
Since the airflow contained biological particles and carbon dioxide, it could not be 
exhausted into the lab environment and had to be filtered through a ventilation system. In 
instances where the biological particles were of great concern, a bleach trap could be 
implemented within the fume hood. The bleach trap would filter any particles from the 
airflow, while the gasses would continue through the ventilation. This trap could be 
emptied, and the contents disposed of following standard procedures. 
2.3.2 Air Delivery System Operation 
 The air delivery system was operated according to the procedure outlined in 
Appendix Z. The incubator was first powered on and allowed to stabilize at 37°C. It 
would stabilize near 37°C within 1hour, but took close to 8 hours to settle on 37°C. An 
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empty testing device was placed within the incubator and attached to the tubing to 
complete the network. If necessary, a new program was uploaded to the Arduino 
controlling the breathing cycle. The temperature and humidity circuit were powered on, 
followed by solenoid valve circuit and the flow controller. The first bubbler chamber was 
filled with fresh water to a specified level. If the hot plate was needed, it was then 
powered on and set at the correct temperature. The main valve of the gas tank was 
opened and the pressure on the regulator set to between 6 and 10 psi. Airflow was run 
through the system for 30 minutes to 1 hour to allow the temperature and humidity of the 
air to stabilize. To begin experiments, the test device was removed and replaced with a 
cultured device. After the experiment ended, a new device would be placed in the system, 
or shutdown procedures would be performed. 
2.4 Computational Fluid Dynamics Simulations 
 Computational fluid dynamics (CFD) simulations were performed using Ansys 
Discovery Live. The simulations were necessary to find the inlet velocities of the device 
to mimic the shear forces in specific regions of the nasal cavity. The regions of interest 
were the anterior region, inferior turbinate and middle turbinate. 
 In a previous study by Zhao et al., the researchers investigated the shear forces 
and shear stresses present in human nasal cavities by performing CFD simulations with 
nasal CT scans obtained from subjects (27). This was performed for CT scans of healthy 
and empty nose syndrome patients, to correlate flow mechanics with the symptoms 
experienced by patients. Dr. Zhao’s team assisted by performing a CFD simulation of the 
nose-on-chip device comparing the results to their simulation data on airflow within the 
nasal cavity of healthy patients (28). The simulations were performed in Ansys Discovery 
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Live, where the interior surface of the top of the flow channel was established as the 
region of interest, and wall shear forces were integrated on this plane. The boundary 
conditions of temperature, velocity, pressure, and material were created. Air was selected 
as the fluid at a temperature of 20°C. The fluid velocity varied at the inlet depending on 
the region being simulated. The anterior region, inferior turbinate, and middle turbinate 
shear forces were investigated in this simulation. Once selected in the program, the inlet 
velocity remained constant for the duration of the run. An outlet pressure of 0 pascals and 
a simulation run time of 0.05 seconds were chosen. The boundary walls of the model 
were stiff and immobile, and the membrane surface was treated as an impermeable wall. 
Simulations for each of the nasal regions can be found in Figure’s 13, 14, and 15. 
 




Figure 14: CFD Simulation of wall shear forces like the inferior turbinate of the nasal cavity, Velocity = 17.5 m/s 
 







From these simulations, the optimal inlet velocities to model the nasal regions of 
interest were discovered. The simulation results are summarized in Table 4 below. 
Table 4: Optimal inlet velocities to model select nasal regions and comparison of device wall shear force to shear 




Device Wall Shear 
Force (N) 




5.5 m/s 5.49E-05 6.00E-05 
Inferior 
Turbinate 
17.5 m/s 4.03E-04 4.00E-04 
Middle 
Turbinate 
15 m/s 3.16E-04 3.00E-04 
 
2.5 Flow Calculations  
 After the inlet velocities required to model the shear forces of the select nasal 
regions were obtained, additional calculations needed to be performed to validate the 
nose-on-chip device as an adequate model to simulate the nasal cavity. These calculations 
were performed for each of the three nasal regions of interest. The examples shown are 
for the anterior region.  
 The air flow within the system was governed by a flow controller, which 
regulated the flow rate of the fluid. Therefore, the inlet velocity obtained previously must 
be converted to a flow rate. Once this flow rate (Eq. 1) was established, the continuity 
equation (Eq. 2) was used to determine the velocity at any location within the flow 





(1) 𝑄 = 𝐴 ∗  𝑢 
Where: 
❖ Q is the volumetric flow rate (m3/min) 
❖ A is the area of the inlet to the device (m2) 
❖ The area is calculated as follows: 
(2) 𝐴 = 𝜋 ∗ 𝑟2 = 𝜋 ∗ 0.22 = 1.256 ∗ 10−5𝑚2 








 The volumetric flow rate equation assumed that the fluid is incompressible. This 
assumption must be validated to use the equation. The fluid incompressibility was 
evaluated by using the Mach number, which was a ratio of the fluid velocity over the 
speed of sound. In this test, if the ratio was greater than 0.3, then the fluid was 
compressible. If it was less than 0.3, the fluid was incompressible and the assumptions 









❖ M is the Mach number 








❖ Thus, the volumetric flow rate is calculated as 0.02 
❖ 0.02 < 0.3, so the flow is incompressible 
 The water hammer effect was investigated. The water hammer effect is caused by 
a barrier suddenly blocking fluid progression. This creates a large backpressure within 
the system, as the entire volume of fluid is slammed to a halt in a very short time span. In 
some instances, backpressures can be magnitudes larger than the operating pressure of 
the system. This effect has been known to cause rupturing, pipe failure, or equipment 
failure in some applications (29). Within the bi-directional air flow system, which 
operated using the opening and closing of solenoid valves, this effect could cause 
increased back pressure toward sensitive equipment, potentially damaging the sensors or 











❖ dP is the change in pressure (kPa) 
❖ du is the change in velocity (m/s), 0.97m/s 
❖ l is the length of tubing (m), 1m 
❖ t is the duration of valve closure (s), 0.05s 
❖ Thus, the pressure change is 101 kPa 
 The hydraulic diameter of the flow channel is used to calculate additional 
parameters, such as the wall shear stress or Reynold’s number. The hydraulic diameter is 
often considered the effective diameter of a channel for fluid flow. This is the primary 
diameter in which fluid flow will occur within the channel. The hydraulic diameter is 
calculated using equation 5. 





❖  𝐷𝐻  is the hydraulic diameter for a rectangular channel (mm) 
❖ w is the width of the channel (mm), .00625m 
❖ h is the height of the channel (mm), 0.004m 
❖ Thus, the hydraulic diameter is 0.00487m 
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 The Reynold’s number is primarily used to evaluate the flow classification based 
on the flow characteristics. The Reynold’s number is a dimensionless velocity. The flow 
classification of the Reynold’s number can be laminar, transitional or turbulent. For 
laminar flow, the Reynold’s number is less than 2300. For transitional flow, it is between 
2300 and 4000. For turbulent flow, it is greater than 4000. The assumption used for flow 
within the device was that it is laminar, so it was crucial to verify this using the 
Reynold’s equation as follows. 





❖ Re is the Reynold’s number, where 
❖ Re < 2300 is laminar 
❖ 2300 < Re < 4000 is transitional 
❖ Re > 4000 is turbulent 
❖ 𝜌 is the density of humid air, 1.23 kg/m3 @ 20°C 
❖ u is the velocity in the rectangular channel (m/s), 2.76 m/s 
❖ 𝜇 is the dynamic viscosity of humid air, 1.79x10-5 Pa*s @ 20°C 
❖ 𝐷𝐻  is the hydraulic diameter of a rectangular channel, 0.00487m  




 The wall shear stress within the device can be calculated using the laminar flow 
equation (24). The equation is valid for rectangular channels and has several assumptions, 
primarily that the flow is laminar and the height to width ratio is less than 1.3. If these 
assumptions are met, then the equation can estimate the wall shear stress within the 
channel. This equation and method of calculating the wall shear stresses have been 







) ∗ (𝑛 + 1) 
Where: 
❖ 𝜏𝑤 is the wall shear stress (Pa) in a rectangular channel 
❖ w is the width of the channel (m), 0.00625m 
❖ h is the height of the channel (m), 0.004m 
❖ 𝜇 is the dynamic viscosity of humid air, 1.79x10-5 Pa*s @ 20°C 




< 1.3, then m and n are constants following, 





 and 𝑛 = 2 






2.6 RPMI 2650 Cell Cultivation 
 RPMI 2650 human nasal epithelial cells were obtained at passage zero from 
(Sigma PHE). Cells were cultured in T-25 Flasks (Corning 430639). Cells were 
maintained using Eagle’s Modified Essential Medium with L-glutamine, sterile filtered 
(ATCC 30-2003, EMEM), supplemented with 10% fetal bovine serum (FBS), 1% non-
essential amino acid (NEAA), and 1% penicillin-streptomycin (P/S). Cell medium was 
changed every 2-3 days and upon reaching 80% confluent the cells were passaged. Upon 
reaching passage 2, cells were frozen at 1x106 cells/mL until needed for experiments. 
Cell vials were thawed as needed for experiments and culture techniques remained the 
same. RPMI 2650 cells at passage 2 through 6 were used for experiments. 
 To prepare for experiments, the transwell inserts underwent a treatment process to 
ensure their suitability for cell adhesion. For the PDMS membranes, this procedure 
involved plasma etching to create a cell adhesive surface, UV treatment, collagen 
(5µg/cm2) and poly-l-lysine (5µg/cm2) treatment. The polyester membranes were already 
treated for cell culture, and they were additionally subjected to a UV treatment followed 
by collagen treatment (5µg/cm2). Both membrane surfaces were washed with PBS in 
advance of cell seeding. 
 Optimization trials were performed to determine the best seeding density to seed 
cells on the basal side of the membrane. The cells were required to reach confluency by 
day 7, to be ready for experiments. Literature was consulted to determine seeding 
densities previously used with the RPMI 2650 cells on transwell inserts. A range of 
60,000cells/cm2 to 1x106 cells/cm2 was found (19, 20). Incremental values between these 
two extremes were tested. The most optimal density was found to be 625x105 cells/cm2. 
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Lower seeding densities were unable to reach confluency in 7 days. Seeding densities that 
were greater had a potential to create cell clusters that risked becoming detached from the 
membrane surface.  
To begin cell seeding, the transwell inserts were inverted, so that the basal surface 
of the membrane was facing upward. A 10µl drop of cell suspension (200,000 cells/mL) 
was gently added to the middle of the membrane surface. The inserts were placed in an 
incubator (37°C, 5% CO2) for 1 hour, to allow cells to adhere to the membrane surface. 
After adhesion, excess media was wicked from the surface of the membranes using a 
sterile gauze patch. The inserts were carefully rotated to be upright and placed into the 
insert chambers of the nose-on-chip devices, taking caution not to touch the bottom 
membrane to any surfaces. To sustain the cells, 40µl of media was added to the apical 
compartment of the membrane, which slowly diffuses across to the basal side to the cells 
maintained at the air liquid interface (ALI). The cell attachment site can be seen in Figure 
16. Media was aspirated and fresh media added every two days, and immediately prior to 
experimental trials. The device was covered by the lid and stationed inside a petri dish 




Figure 16: Cell Attachment Site on Transwell Insert 
2.7 Experimental Procedures 
 Experiments were performed using the nose-on-chip device in stationary and 
dynamic conditions. The stationary conditions were simulated by placing the device 
uncovered in an incubator for specified periods of time. The dynamic conditions were 
simulated by integrating the device in the bi-directional air flow system and simulating a 
dynamic breathing pattern over specified timeframes. The time frames were varied to 
assess the effects of each condition over time. The time points of interest can be found in 
Table 5 for each study. All dynamic experiments were performed while modeling the 
anterior region of the nasal cavity. A single device containing three inserts was used for 
each condition and time point. After the experimental trials are performed, the samples 
can then be fixed and stored, or immediately undergo fixation and the staining or 
immunohistochemistry procedures.  
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Table 5: Summary of Experimental Trials 
  Alcian Blue Assay Cytoskeletal Remodeling  
Duration Stationary Dynamic Stationary Dynamic 
0 Hours X   X   
0.5 Hours X X     
2 Hours X X X X 
6 Hours X X X X 
  
For the stationary protocols, media was refreshed, and the device removed from 
the petri dish and placed inside the incubator (37°C, 5% CO2, 85-95% RH) for the 
specified time frame. The 0-hour trials served as the baseline for cultures that had not 
been exposed to either condition. After exposure for the specified time frame, the inserts 
were removed and fixed before undergoing staining or immunohistochemistry 
procedures. 
 For the dynamic protocols, the air delivery system was set up prior to the start of 
the experiments. The solenoid valve array was pre-loaded with a breathing pattern 
featuring 3-second inhalation and 3-second exhalation phases that constantly cycle. All 
the system components were powered on and a sample device was mounted inside the 
incubator and attached to the airflow tubing. The incubator was turned on and settled at 
37°C before beginning the experiment. The flow meter was calibrated to 4.14 LPM to 
mimic the shear stresses present in the anterior region of the human nasal cavity. The first 
bubbler chamber was filled with 90mL of fresh water and placed in the system. The 
outlet valve on the regulator was loosened so that it was entirely closed, and the gas 
cylinder valve was slowly opened. The regulator valve was slowly opened until a 
pressure of 6-10 psi was established. The flow meter was monitored to ensure the correct 
flow rate was being delivered. Adjustments were made to the system as necessary to 
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ensure the flow rate reading is optimal. The temperature and humidity of the air flow was 
monitored via a digital readout from the Arduino monitoring circuit. The system was run 
for one hour, after which the temperature would stabilize between 19.5°C and 22.5°C. 
The humidity would stabilize between 88.5% and 91%. The apical compartment media 
was refreshed, and the device was transported to the air delivery system. The sample 
device was removed, and the experimental device was mounted in the system as the 
barbed nozzles were attached to the system tubing. The incubator was closed, and a timer 
was started for the duration of the experiment. After the time had expired, the device was 
promptly removed from the incubator. The inserts were fixed before undergoing staining 
or immunocytochemistry procedures. 
2.7.1 Alcian Blue Staining Procedure 
 Alcian Blue is a basic dye that derives its color from the presence of copper. It is 
commonly used to target acidic mucins in histology. The molecules of the stain are 
positively charged and attracted to the negative mucins present in the samples (31). 
Depending on the pH of the alcian blue solution, it will target different mucin groups. 
The most useful pH levels are 2.5 and 1, which each target different mucin groups. A pH 
of 2.5 is used to stain goblet cells and carboxylated mucins, while a pH of 1 is used for 
adenocarcinomas and intestinal goblet cells (31). Once stained, the mucins will be 
evident under an optical microscope and will appear blue in hue. The darker the blue 
color, the greater the presence of mucins in the sample. A nuclear fast red counterstain is 
often used to highlight the nuclei of the cells (32). 
 The necessary reagents were prepared prior to staining. 3% glacial acetic acid was 
created by mixing glacial acetic acid (Sigma, ACS reagent, 242853-2.5kg) with distilled 
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water to create a 3% (v/v) solution. The alcian blue solution was created by mixing alcian 
blue powder (Fisher, ACROS Organics, 8GX) in 3% glacial acetic acid to form a 1% 
(w/v) solution. The pH of the solution was verified using a pH meter and adjusted with 
3% acetic acid until a pH of 2.5 was achieved. The 4% paraformaldehyde (Microscopy 
Sciences, Cat. 157.4) was purchased as a solution, premixed to 4% PFA in water. 
 Staining was performed following the procedure in Appendices T and U. Samples 
were fixed and stained with the membrane attached to the support. In each step, 40µL of 
the solution was first added to the apical compartment, then the sample was submerged in 
200µL of the solution within a 96-well compartment. Following completion of each step, 
a gauze patch was used to remove any excess remaining inside the apical compartment. 
Samples were fixed in 4% PFA for 20 minutes. Samples were then washed with 3% 
acetic acid for 3 minutes. Next, the samples were stained with alcian blue (1% w/v, pH 
2.5) for 30 minutes. The samples were then washed twice with 3% acetic acid, first for 5 
minutes, then for 3 minutes. The samples were dried and then imaged attached to the 
support or removed and mounted to a glass slide. 
2.7.2 β-tubulin and actin immunocytochemistry 
 The immunocytochemistry procedure is described in detail in Appendix S. The 
samples were first fixed following the procedure mentioned in the ‘Alcian Blue Staining 
Procedure’ section. Following fixation, the membranes were gently removed by sliding a 
#11 scalpel between the membrane and support. The resulting membrane samples were 
placed in a 96-well compartment to undergo the procedure. The samples were 
permeabilized by Triton® X-100 and 0.1% BSA agent in PBS for 20 minutes. A PBS 
wash followed, after which the samples were blocked with 5% BSA in PBS (blocking 
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buffer, BB) overnight at 4°C. Immediately following removal of the blocking buffer, the 
1:100 of βTubulin (D-10) (sc-5274, Santa Cruz, raised in mouse) to BB was added to the 
wells overnight at 4°C. Following a PBS wash, the secondary antibody, 1:250 of Goat 
anti-Mouse- Alexa Fluor® 546 (Invitrogen) to BB was added to the cells for 1 hour. 
After removal, a PBS wash was performed. Next, 1:40 of Phalloidin- Alexa Fluor 488 to 
BB was added to the cells for 45 minutes. A PBS wash was performed and DAPI 
(5µg/mL in PBS) was added to each well. A final PBS wash was performed, and the 








3. RESULTS AND DISCUSSION  
3.1 PDMS Membrane Evaluation 
 The custom PDMS membranes were investigated to characterize the features and 
evaluate its efficacy for use in a nose-on-chip model. Creating a custom PDMS 
membrane from start to finish is a time-consuming process, however it is much more cost 
effective than purchasing a commercially available membrane. The materials necessary 
can be used to create numerous membrane samples, as well as being useful for other 
research projects. 
3.1.1 PDMS Membrane Characteristics 
The custom PDMS membrane was investigated to determine the average pore 
size, interpore spacing, and porosity of the membrane samples. The target features 
(Figure 17) were pores that were 10µm in diameter, with an interpore spacing of 10µm, 
having a porosity of 35-40%. The membrane analysis investigated 7 unique membranes 
created using the membrane techniques outlined in this paper. The results of the 
membrane analysis are summarized in Table 6. The results indicate membrane features 




Figure 17: Image of the PDMS membrane showing target features 




Average Standard Deviation 
Pore Size (µm) 35 10.63 0.86 
Pore Spacing (µm) 35 9.87 0.99 
 Porosity 7 37.36% 2.33% 
The goal of the custom membrane was to create a reproducible membrane that 
had predictable features. Two other designs were tested, the first being 5µm diameter 
pores, 10µm spacing and the second being 20µm diameter pores, 20µm spacing. Each of 
these designs presented its own flaws and difficulties. During the photolithography stage 
with the 5µm diameter pore photo film mask, it proved very difficult to create posts that 
were so small. These posts would have an increased tendency to break, as their height 
was much greater than their diameter, so it would not be a good choice for a reproducible 
design. The second membrane had pores that were larger than the average diameter of the 
cells, of roughly 10µm. These large pores could present issues as the cells may migrate 
and cultivate within the pores, instead of forming a confluent layer on the surface. Due to 
these considerations, and the success of the 10µm pore design, it was chosen as the 
optimal membrane for the research. 
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3.1.2 Membrane Thickness  
Another benefit of the custom membrane is the ability to create either a through-
pore membrane or a microwell membrane. Through-pore membranes are commonly used 
in transport studies, as they provide a means in which particles or cells can migrate 
through a medium. These membranes are typically used with transwell inserts, as they 
allow transport between apical and basal compartments.  
Conversely, in microwell membranes, openings do not penetrate the entire 
thickness of the membrane. Microwell membranes are used in microencapsulation studies 
and have been used to create pancreatic islets (33). Another potential use is as a tissue 
engineering scaffold. Microwells have also seen use in sensing applications to trap 
particles in nasal models (34). The microwell membranes could be used to create a 
different surface topography on the transwell inserts or used in similar particle trapping 
sensing applications.  
Membrane samples of both types were isolated and cryo-sectioned, and optical 
microscope images are in Figure 18. The samples were dyed to increase the visibility of 
the pores. The membrane thickness of the samples ranged from 25 to 35 µm.  
 
Figure 18: Images of membrane thickness. Microwell membrane (left) and through-pore membrane (right). 
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Curing immediately after spin coating the PDMS membrane layer is crucial to 
obtain a through-pore membrane. If this is not performed, the PDMS will begin to form a 
film layer over the top of the SU8-50 posts as it cures, causing a microwell membrane. 
This appeared to be the major factor determining the creation of a microwell or through-
pore membrane. 
3.1.3 Results and Discussion 
The results of the membrane analysis show that the method described is viable to 
create both through-pore and microwell membranes. The membrane features were very 
similar to the target features, and consistent across membranes created by different 
molds. The through pore membranes show some through pores that are not entirely 
perpendicular to the sample, though this is not expected to be a concern. Standard 
procedure for creating many commercially available membranes involved track-etching, 
which creates through pores at various angles along the membrane. The through pores 
created from this method are comparable to the angled pores from track-etching. One of 
the benefits of the SU8-50 wafers is that the mold is reusable once the membrane is 
removed. If the posts are not damaged, which should not occur with careful removal of 
the membrane, the wafer can continue to be reused. This is convenient as it allows for 







3.2 Effects of Wall Shear Stresses and Wall Shear Forces on Mucus Production  
3.2.1 ImageJ analysis  
To assess the mucus production of the RPMI 2650 cells under stationary or 
dynamic conditions, an alcian blue assay was used to stain the mucins contained in the 
mucus and goblet cells a blue hue. This stain was repeated for both conditions at specific 
time points and images were obtained with an optical microscope, ensuring the same 
settings were used to capture each image. ImageJ and a plugin titled Color Inspector 3D 
were used to analyze these images. Color density mapping was performed for each image 
to compare the quantity of blues present in each image. This would allow a comparison 
between the mucus production, as the darker blues that are present are an indicator for 
increased mucus production. 
The color density map generates a cube space in which the x, y, and z axis are red, 
green, and blue, respectively. Each axis runs from the origin (0,0,0) to 255 at the far end 
of the cube. Each coordinate within the cube is assigned a color from the 256-color scale. 
The cube contains 16,777,216 possible combinations. Color Inspector 3D analyzes the 
image and assigns each pixel a color value, which corresponds to a coordinate location in 
the cube space. This allows a visual representation of the colors present in the image. 
This data can also be modified to display the data based on certain algorithms.  
Two useful modifiers are the histogram and median cut. The histogram function 
displays the density of the most common colors found in the image. This creates a plot of 
circles, where the larger each circle, the more present the color. The median cut function 
uses an algorithm to sort the data and compare it to the median. Median cut is commonly 
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used for color quantization (35). Both settings allow for the generation of a look-up table 
(LUT), which reports the RGB data for each color, its frequency, and its density. This is 
useful in determining the percentage of each color within the image. 
Color density maps were created using the all colors, histogram, and median cut 
algorithms. Color density maps for a sample from each of the time points is in Figure’s 
19, and 20. 
 
Figure 19: Color density mapping for Stationary cultures (Day 5) cultured on polyester membranes and stained 




Figure 20: Color density mapping for Dynamic cultures (Day 5) cultured on polyester membranes and stained using 
alcian blue 
3.2.2 Mucus Production Prediction Equation 
Analysis of the color density mapping created by the median cut function of Color 
Inspector 3D was performed. The analysis was performed by assigning all the colors 
found in the image to the 10 average colors found. These colors were then divided into 
dark blue, light blue, and white categories based on their density. A summary of the 
values from this analysis can be found in Table 7.  
Table 7: Analysis of density of light and dark mucins produced by RPMI 2650 cells 
 
The data points in the table can be plotted to observe trends in the data, found in 
Figure 21. A line of best fit can be applied to model the equation to predict the average 
percentage of each mucin type present in an RPMI 2650 sample at various durations of 
S1 S2 S3 S1 S2 S3 D1 D2 D3 D1 D2 D3
0 12.6 12.4 12.5 24.7 37.3 43.6
0.5 25 25.6 25.1 55.8 62 50.1 31.6 37.3 32.3 56 50.3 55.3
2 31.5 37.5 37.6 55.6 37.7 37.6 37.6 37.8 37.5 50 49.8 50.2
6 37.4 31.2 37.5 50.2 56.4 50.1 46.3 44.4 44.6 53.7 43.2 43.5
S4 S5 S6 S4 S5 S6 D4 D5 D6 D4 D5 D6
0 12.5 12.5 37.3 37.5
0.5 25.1 25 50.1 50.1 32.1 38.1 55.8 49.5
2 37.4 43.8 37.5 50.2 43.8 50.3
6 31.9 55.7 44.8 43.8 49.9 55.2 43.9 37.8
Data Analysis of Alcian Blue Color Density Mapping - Polyester 0.4µm Membranes
Duration
Stationary Dynamic
Dark Mucin Light Mucin Dark Mucin Light Mucin
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exposure to stationary or dynamic airflow. At least three images per category were 
analyzed to provide the data. The difference of these equations can be obtained to create a 
prediction equation that describes the increase in mucins present in a dynamic culture 
versus stationary conditions. 
  
Figure 21: Plot of Mucus production determined by analysis of alcian blue stain 
 Analyzing only the dark mucus values will provide a comparison of 
increases in mucus production. Figure 22 features a comparison of density of the dark 
mucus in both the stationary and dynamic conditions at different time points, as well as 
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Figure 22: Mucus production data and prediction equations 
3.2.3 Results and Discussion 
The color density mapping shows significant differences between cultures in 
stationary conditions (stagnant airflow) versus cultures in dynamic conditions (air 
delivery system, anterior region). These differences are compared in Figure 23 for the 























Mucus Production Prediction Equation
Predicted Dark Stationary Predicted Dark Dynamic




Figure 23: Comparison of stationary and dynamic cultures for 2-hour and 6-hour time points 
The results indicate an increase in dark hues in the alcian blue stain for the 
dynamic samples. The darker hues are indicative of an increase in acidic mucins at those 
locations, which is a strong indicator of increased mucus concentration. These results 
show that the wall shear forces, and wall shear stresses caused by the bi-directional flow 
influence the mucus production of RPMI 2650 cell cultures.  
The mucus prediction analysis confirms that dynamic conditions have higher dark 
mucin content than stationary trials. This also shows that for increased durations of 
exposure, there is an increased presence of darker mucins. The density of the light mucins 
stays relatively constant between all the samples. Using regression analysis, a prediction 
equation was obtained to predict the percentage of dark mucus for stationary and 
dynamic conditions at varying time points. A power equation was found to best model 
the data. With an increase in data points, a more advanced equation may be generated. 
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The resulting equations can be used to predict the mucus produced by RPMI 2650 cells 
exposed to dynamic airflow conditions mimicking the wall shear forces found in the 
anterior region of the nasal cavity. 
(8)  𝑀𝐷 = 24.109 ∗ 𝑡
0.1672 + 12.5 [SE = 0.837] 
(9)  𝑀𝑆 = 16.183 ∗ 𝑡
0.2314 + 12.5 [SE = 3.448] 
(10) 𝑀𝐼 = 24.109(𝑡
0.1672 − 0.6712 ∗ 𝑡0.2314) 
Where: 
❖ 𝑀𝐷 is the predicted percent density of dark blue or acidic mucus 
produced by RPMI 2650 cells for bi-directional airflow such that 
WSS = 0.1 Pa, WSF = 5.49*10-5 N 
❖ 𝑀𝑆 is the predicted percent density of dark blue or acidic mucus 
produced by RPMI 2650 cells in a stationary setting within an 
incubator 
❖ 𝑀𝐼 is the predicted increase in dark blue or acidic mucus 
production for RPMI 2650 cells exposed to the bi-directional 
airflow, compared to stationary conditions 
❖ t is the duration of exposure for the RPMI 2650 cells (hours) 
 These equations can be used to predict the dark blue or acidic mucus percentage 
present on a sample after a specified time length. They can also predict the increase in 
mucus production for cells exposed to bi-directional air flow, mimicking the anterior 
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region, versus stationary cells at specified time lengths. These equations can be used to 
determine the desired percentage of acidic mucus in a sample. 
The alcian blue mucus production data was analyzed with a two-way Anova. The 
results of a two-way Anova show that for the dark mucus production data, there was a 
statistically significant difference because of time, condition, and their interaction (Figure 
24). For the light mucus production, a significant difference between the effects were not 
shown. 
 
Figure 24: Two-Way Anova Results for Dark Mucus Production 
3.3 Effects of Shear Stresses on Cytoskeletal Remodeling 
3.3.1 β-tubulin and Actin Immunocytochemistry 
The integrity and structure of the β-tubulin and actin fibers were evaluated using a 





Figure 25: Images of β-tubulin (Green) and Actin fibers (Red) for two culture conditions 
The cellular cytoskeleton is critical to maintaining the barrier that epithelial cells 
present, as it is the framework for cell-cell junctions (36). β-tubulin is a main ingredient 
of microtubules which are a major structural component to the cytoskeleton and provide 
its shape. Microtubules also have many other functions, such as transport and are 
responsible for polarizing epithelial cells (36). Likewise, actin is a protein that enables 
tissues to react to physiological mechanical stresses and adapt to these changes (36). 
Thus, in a scenario applying dynamic shear stresses to cell layers, both will play a 
significant role.  
The β-tubulin fibers appear to have a decreased integrity for the dynamic 
conditioned culture, compared to the stationary cultures. This would indicate that the 
shear forces and shear stresses produced by the bi-directional airflow have an impact on 
the cytoskeleton and cause an increase in the fragmentation of the β-tubulin fibers. The 
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actin fibers do not show significant changes, and their structure is preserved for both 
conditions.  
3.3.2 Results and Discussion 
The anterior region’s shear forces, used for these assessments, are much lower 
than the middle and inferior turbinate regions. Repeating this assessment using airflow 
mimicking either of the turbinate regions is likely to show an increased fragmentation of 
the β-tubulin fibers. Undergoing such an increase in shear forces, the actin fibers may 
also be influenced. Increasing the wall shear forces in the model may also cause an 
increase in the disruption of the cytoskeletal fibers. These results indicate how the 
cytoskeleton of RPMI 2650 cells are influenced by shear forces and stresses resultant 
from bi-directional airflow modeling the anterior region of the nasal cavity. A more 
advanced cellular model of the nasal cavity could be used in place of the RPMI 2650, to 
determine how the addition of multiple cell types, and cilia into the model would change 
the cytoskeletal remodeling. 
3.4 Nose-on-Chip Airflow Channel Optimization 
 The nose-on-chip model used in this research was based on mimicking the 
wall shear forces of the nasal cavity. The device was successful for simulating the 
anterior region, however, to mimic the inferior and middle turbinate regions, the 
velocities necessary to replicate the shear forces would cause a Reynold’s number outside 
of the laminar region. Optimization trials were performed on the airflow channel to 
decrease its height, and in turn decrease in the velocities necessary to replicate higher 
wall shear force values. 
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In addition to the wall shear forces, the nasal cavity regions also undergo wall 
shear stresses. These wall shear stresses vary in magnitude depending on the region and 
can also be simulated using the nose-on-chip device. The wall shear stress values were 
calculated for different airflow channel heights using Equation 7. The most optimal 
airflow channel height to replicate the wall shear stresses of each region was determined. 
3.4.1 Calculations 
The necessary velocity required to replicate the wall shear stresses of each region 
for the heights was determined. Many parameters were investigated for each of the 
channel heights, and the analysis of several formulations can be found in Table 8. The 
wall shear stresses were calculated and compared to the values found in the nasal cavity. 

























Anterior 5.5 927 0.1024 1.4375 
Inferior 17.5 2949 N/A 1.2 
Middle 15 2527 N/A 1.18 
1 
Anterior 6 1429 1.4536 1.4375 
Inferior 5 1191 1.2113 1.2 
Middle 4.87 1160 1.1798 1.18 
0.7 
Anterior 3.02 750 1.4381 1.4375 
Inferior 2.52 626 1.2000 1.2 
Middle 2.48 616 1.1809 1.18 
0.65 
Anterior 2.65 663 1.4541 1.4375 
Inferior 2.2 551 1.2072 1.2 
Middle 2.15 538 1.1797 1.18 
0.6 
Anterior 1.58 580 1.4716 1.4375 
Inferior 1.33 474 1.2029 1.2 
Middle 1.3 466 1.1837 1.18 
0.265 
Anterior 0.46 122 1.4470 1.4375 
Inferior 0.39 103 1.2268 1.2 
Middle 0.375 99 1.1797 1.18 
 From the summary, the 0.265mm and 0.7mm channels were chosen to 
undergo CFD simulation. These channels maintain lower velocity values and result in 
optimal wall shear stresses. 
3.4.2 CFD Simulations 
CFD simulations using Ansys Discovery Live were performed to verify the wall 
shear forces and wall shear stresses for channel heights of interest from the previous 
calculations. In addition, the velocity profile of each of the channel heights was 
investigated to ensure there were no adverse effects. To lengthen the transitional distance 
from the inlet to the channel, the loft was lengthened to encompass the entire interior of 
the barbed nozzles. The simulation results for the wall shear forces for the 0.7mm 
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channel are found in Figure’s 26, 27, and 28. For the 0.7mm channel images, a standard 
velocity profile was chosen. 
 
Figure 26: Velocity Profile and Wall Shear Force Graphs for a channel height of 0.7mm modeling the anterior region 
 
 





Figure 28: Velocity Profile and Wall Shear Force Graphs for a channel height of 0.7mm modeling the inferior 
turbinate 
 The same analysis was performed for the 0.265mm channel. Images of the 
velocity profile and wall shear forces can be found in Figure’s 29, 30, and 31. For the 
0.265mm channel images, a standard velocity profile was chosen. 
 





Figure 30: Velocity Profile and Wall Shear Force Graphs for a channel height of 0.265mm modeling the middle 
turbinate 
 
Figure 31: Velocity Profile and Wall Shear Force Graphs for a channel height of 0.265mm modeling the inferior 
turbinate 
Using the wall shear forces found in the simulations were used to derive the wall 
shear stress estimates. The wall shear stress is the ratio of the wall shear forces over the 



















Device WSS (Pa) 
4 
Anterior 5.5 927 5.49E-05 0.24 
Inferior 17.5 2949 4.03E-04 1.8 
Middle 15 2527 3.16E-04 1.4 
0.7 
Anterior 3.02 750 2.33E-04 1.04 
Inferior 2.52 626 1.89E-04 0.84 
Middle 2.48 616 1.86E-04 0.83 
0.265 
Anterior 0.46 122 3.54E-04 1.57 
Inferior 0.39 103 3.00E-04 1.33 
Middle 0.375 99 2.88E-04 1.28 
3.4.3 Results and Discussion 
The results of the computation fluid dynamics simulations indicate that the 
calculated wall shear stress values are accurate. A comparison of the values for each 
region and channel height can be found in Figure’s 32, 33 and 34. 
 































Figure 33: Comparison of Simulated WSS values versus calculated WSS values for the Middle Turbinate 
 
Figure 34: Comparison of Simulated WSS values versus calculated WSS values for the Inferior Turbinate 
From the analysis, the calculated and computational values are within 0.7Pa range 
of each other. The wall shear stress data is summarized in Table 10. The data indicates 
that the calculated wall shear stress values are like the wall shear stresses found in the 
nasal cavity (27, 28). The summary of wall shear force data is in Table 11. The WSF in 





















































good representation of the middle and inferior turbinate. The 0.6mm channel represents a 
middle ground with comparable WSS and relatively high WSF values. The WSS of the 
4mm anterior region is lower than that of the nasal cavity, due to the height of the 
channel. Despite this, it is the best model for the WSF of the anterior region. 



















Anterior 5.5 927 0.24 0.10 1.4375 
Inferior 17.5 2949 N/A N/A 1.2 
Middle 15 2527 N/A N/A 1.18 
0.7 
Anterior 3.02 750 1.04 1.44 1.4375 
Inferior 2.52 626 0.84 1.20 1.2 
Middle 2.48 616 0.83 1.18 1.18 
0.265 
Anterior 0.46 122 1.57 1.45 1.4375 
Inferior 0.39 103 1.33 1.23 1.2 
Middle 0.375 99 1.28 1.18 1.18 
 
















Anterior 5.5 927 5.49E-05 6.00E-05 
Inferior 17.5 2949 4.03E-04 4.00E-04 
Middle 15 2527 3.16E-04 3.00E-04 
0.7 
Anterior 3.02 750 2.33E-04 6.00E-05 
Inferior 2.52 626 1.89E-04 4.00E-04 
Middle 2.48 616 1.86E-04 3.00E-04 
0.265 
Anterior 0.46 122 3.54E-04 6.00E-05 
Inferior 0.39 103 3.00E-04 4.00E-04 
Middle 0.375 99 2.88E-04 3.00E-04 
 
Since the device is so inexpensive to produce, it is possible to use a different 
channel height to model each region. This channel height is also variable depending on 
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which factor is most important, the flow velocity within the cavity, the WSS, or the WSF. 
The outer dimensions of the device remain constant to ensure compatibility with the 
airflow delivery system. 
Future work involving the nose-on-chip device would entail optimization of the 
parameters to obtain a channel height and velocity combination that results in velocity, 
wall shear force and wall shear stress values that accurately simulate each region. By 
simulating the nasal cavity for all three parameters, the model would provide additional 














Experiments were performed using the nose-on-chip device and bi-directional air 
flow system, with the RPMI 2650 cell culture as a model for the nasal cavity. The mucus 
secretion and cytoskeletal remodeling were investigated for the cells in dynamic 
conditions (cells exposed to the bi-directional air delivery system) compared to stationary 
conditions (cells placed stationary within an incubator) for different time durations. The 
results of an alcian blue assay show an increase in mucus production for cells exposed to 
wall shear forces (WSF) and wall shear stresses (WSS) generated by the bi-directional 
airflow system. Additionally, as the duration of exposure is increased, the mucus 
production is increased as well. The results from modelling the anterior region of the 
nasal cavity were plotted and prediction equations were formed to predict the increase in 
mucus production for specific durations of exposure. 
Cytoskeletal changes were observed in the RPMI 2650 cells, comparing dynamic 
to stationary conditions. The immunofluorescent images show evidence of a disruption of 
the β-tubulin fibers for cultures exposed to the air flow WSS and WSF. The actin fibers 
did not show evidence of modifications. The integrity of the cytoskeleton is crucial, as 
the disruption of cytoskeletal fibers can weaken nasal defenses and open pathways for 
increase particle uptake. 
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Finally, the nose-on-chip device was analyzed to provide an optimized channel 
height to model the various regions of the nasal cavity. Due to the affordability of 
printing duplicates of the device, it is possible to alter the channel height to more 
adequately model specific regions. The channel height and flow rate provide precise 
control over the WSS and WSF generated in the device flow channel. These parameters 
were tailored to fit the profile found in the three regions of the nasal cavity desired for 
modeling. By comparing the computational and calculated values, the resulting WSS 
values were verified. 
For this research, a bi-directional airflow delivery system and custom nose-on-
chip device were created. When used in conjunction, the resulting platform provides a 
model of the nasal cavity. This platform represents a new approach to investigate the 
respiratory system. By manipulating the flow rate parameters and channel height, the 
nose-on-chip device can easily replicate different regions of the nasal cavity. The bi-
directional airflow system was designed to be modular, and its settings and components 
can be customized to suit a variety of experiments. The nose-on-chip device and bi-
directional air flow system can provide the framework for future experiments 










Appendix A: Protocol for Transwell Support Fabrication 
Goal: Procedure to create a transwell support using the transwell mold. 
Ingredients: 
• Sylgard 184 Elastomer Base (Polydimethylsiloxane (PDMS)) 
• Sylgard 184 Curing Agent 
• Ease Release 200 Release Agent 
• Transwell Support Mold 
• Cup, Stirring Rod, and Dropper 
• Vacuum Chamber and Vacuum Pump 
• Scale and Calibration Weights 
Procedure: 
1. Ensure the oven is not in use, and the temperature is set to 60°C. Adjust if 
necessary. 
2. Remove the cover from the scale and remove scale from plastic protector. 
Turn on scale and use the calibration weights to ensure the scale is 
properly calibrated. If not calibrated properly, consult calibration guide to 
recalibrate the scale before continuing. 
3. Weigh out 10g of Sylgard 184 Elastomer Base in a clear cup. 
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4. Weigh out 1g of the Sylgard 184 Curing Agent into the clear cup. (10:1 
ratio of elastomer base to curing agent). 
a. Note: Do not tare or zero the scale during this step. The scale can 
lose accuracy when measuring small amounts with the readout less 
than ~1g. 
5. Mix the PDMS using the stirring rod for two minutes. 
6. Place the cup of PDMS in the vacuum chamber. Turn on the vacuum 
pump and ensure there is a good seal on the chamber. When a seal is 
achieved, leave the cup in the chamber for 13-15 minutes. Continue to 
Step 7 during this time. 
a. Note: The top portion of the chamber can be moved around while 
the pump is active to move the rubber seal into position. The 
position of the valve can also be checked as well. 
7. Open the transwell support mold using the hex key. Place the support 
mold pieces on a paper towel on the surface of the desk.  
8. Spray the Ease Release agent on all surfaces of the mold that will 
encounter the PDMS, following the guidelines on the canister. This 
ensures the PDMS is easy to remove from the mold.  
a. Note: This step must only be done the first time using the mold, or 
if it becomes difficult to remove PDMS. 
9. Take a chem-wipe and gently swipe along the areas of the mold that 
contain excess amounts of the release agent. There should be a thin visible 
layer of the release agent on the mold. The mold can then be reassembled. 
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Leave the mold out in ambient air conditions while waiting for Step 5 to 
complete. 
10. Monitor the PDMS in the vacuum chamber. Ensure that the air bubbles in 
the mixture are dissipating. When there are very few (<5) air bubbles 
visible, or 15 minutes has passed, turn off the vacuum and remove the cup 
of PDMS.  
11. Carefully pipette some of the PDMS from the cup into the fill slot of the 
transwell mold. Do not allow excess air to be transmitted into the mold. 
Continue filled the mold until the level of PDMS has reached the top of 
the mold. Add a small amount of PDMS at the top of the flow port, so it is 
slightly overfull. If there are any empty regions, as the PDMS settles, the 
excess amount will fill the empty areas of the mold. 
12. Place the transwell mold in the vacuum chamber for 2minutes to assist 
with the removal of any air bubbles and the PDMS settling. 
13. Remove the mold from the vacuum chamber and place it in the oven for 3 
hours. 
14. After 3 hours, remove the mold from the oven. Allow the mold to cool for 
2-5 minutes. 
15. Unscrew the mold components and carefully separate the two halves. 
Carefully remove the rod from the transwell supports, ensuring they do not 
rip. Place the transwell supports in a secure container for storage. 
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16. Dispose of excess PDMS. Use a chem-wipe to clean uncured PDMS or 




















Appendix B: Silanization of the Silicon Wafer 
Goal: Use chemical vapor deposition to coat the surface of the wafer with silane. This 
prevents the PDMS from bonding to the photoresist or wafer during the spin coating and 
curing process. 
Ingredients: 
• Silicon Wafer and carrying case 
• Silane 
• Fume Hood 
• Vacuum Chamber and Vacuum Pump attached to fume hood 
• Small petri dishes 
• Air spray canister 
Procedure: 
1. Transport the Silicon wafer to the vacuum chamber. 
2. Prepare the vacuum chamber in the fume hood and attach a tube to the 
vacuum nozzle on the fume hood. 
3. Retrieve the Silane and small petri dishes 
4. Carefully spray the surface of the wafer with the air canister at ~9” 
distance from the surface. Take care not to touch the surface of the wafer 
with your gloves. Always grip the wafer from the outer edges, never 
touching the surface. 
5. Place the silicon wafer in the middle of the vacuum chamber. 
6. Place two petri dishes, each in opposite ends of the chamber. 
82 
 
7. Add a few drops of silane (~1mL) into each dish, taking caution. 
Alternatively, a glass pipette can be used to add the silane to each dish. 
8. Activate the vacuum pump and ensure a vacuum seal on the chamber. 
Leave the wafer under the vacuum for 1hour. 
9. After 1 hour, remove the wafer from the vacuum chamber and place it 
back in the carrying case. 
10. Remove the petri dishes from the vacuum chamber and place them in the 
silane excess bin within the fume hood. 














Appendix C: Spin Coating of Sacrificial Layer on a Silanized Wafer 
Goal: Procedure to spin coat the sacrificial layer on the surface of the wafer. This is 
performed prior to spin coating the PDMS membrane, to assist with removal. 
Ingredients: 
• Silanized Silicon Wafer and carrying case 
• Spin Coater 
• Pipette 
• Scale and Calibration Weights 
• Air spray canister 
• Hot Plate 
• Nitrogen gas source 
Preparation: 
o Poly acrylic Acid: 
▪ Neutralize the solution with a saturated solution of NaOH until 
reaching a pH of 7.5 with band indicator test. 
▪ Dilute with distilled water to appropriate concentration (19% w/v) 
o Dextran 
▪ Mix appropriate amounts of Dextran and water in a vial. Place in a 
hot water bath at 90-95°C for complete dissolution. 
Procedure: 
1. Turn on the Spin Coater. 
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2. Open the nitrogen tank valve until a pressure of 60-70 psi is achieved on the 
regulator. 
3. Open the vacuum valve within the fume hood all the way. 
4. Prepare the hot plate and set it to 95°C. Allow it to warm while the next steps 
are completed. 
5. Carefully spray the surface of the wafer with the air canister at ~9” distance 
from the surface. Take care not to touch the surface of the wafer with your 
gloves. Always grip the wafer from the outer edges, never touching the 
surface. 
6. Place the silanized wafer on the center of the chuck of the spin coater. Press 
the “Vacuum” button on the spin coater to hold the wafer in place. 
7. Cut the tip off the dropper pipette, ensuring that there is an easy way to 
calculate 1mL of fluid using the dropper measurements. 
8. Carefully pipette the sacrificial layer onto the center of the wafer, until about 
90% is covered. (~1mL per 1inch wafer diameter). 
9. Close the lid of the spin coater. Select the programmed option on the spin 
coater. 
10. Press start and the programmed operation will begin. 
a. Note: If the screen shows “No Vacuum”  
i. Ensure the vacuum valve is completely open 
ii. Ensure that the “Vacuum” button was pressed 
b. Note: If the screen shows “No CDA” 
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i. Ensure that the nitrogen tank reads 60-70 psi. Anything outside 
of this region will prevent the spin coater from operating. 
11. Once the program has ended and the wafer has come to a stop, open the lid of 
the spin coater. Press the “vacuum” button to release the wafer. Remove the 
wafer from the spin coater and take it to the hot plate. 
12. Place the wafer on the hot plate for 2 minutes at 150°C 
13. Remove the wafer and allow it to cool briefly before placing back on the spin 
coater. 














Appendix D: Spin Coating of a Porous Membrane on a Silanized Wafer 
Goal: Procedure to spin coat the PDMS membrane on the surface of the silanized wafer.  
Ingredients: 
• Silanized Silicon Wafer and carrying case 
• Spin Coater 
• Sylgard 184 Elastomer Base (Polydimethylsiloxane (PDMS)) 
• Sylgard 184 Curing Agent 
• Cup, Stirring Rod, and Dropper 
• Vacuum Chamber and Vacuum Pump 
• Scale and Calibration Weights 
• Air spray canister 
• Hot Plate 
Procedure: 
1. Turn on scale and use the calibration weights to ensure the scale is properly 
calibrated. If not calibrated properly, consult calibration guide to recalibrate 
the scale before continuing. 
2. Weigh out 10g of Sylgard 184 Elastomer Base in a clear cup. 
3. Weigh out 1g of the Sylgard 184 Curing Agent into the clear cup. (10:1 Ratio 
of elastomer base to curing agent). 
4. Mix the PDMS using the stirring rod for two minutes. 
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5. Place the cup of PDMS in the vacuum chamber. Turn on the vacuum pump 
and ensure there is a good seal on the chamber. When a seal is achieved, leave 
the cup in the chamber for 13-15 minutes.  
6. Monitor the PDMS in the vacuum chamber. Ensure that the air bubbles in the 
mixture are dissipating. When there are very few (<5) air bubbles visible, or 
15 minutes has passed, turn off the vacuum and remove the cup of PDMS.  
7. Turn on the Spin Coater. 
8. Go to the condensed dry air source and slowly open the regulator until a 
pressure of 60-70 psi is achieved on the regulator. 
9. Open the vacuum valve within the fume hood all the way. 
10. Locate the hot plate and set it to 95°C. Allow it to warm while the next steps 
are completed. 
11. Carefully spray the surface of the wafer with the air canister at ~9” distance 
from the surface. Take care not to touch the surface of the wafer with your 
gloves. Always grip the wafer from the outer edges, never touching the 
surface. 
12. Place the silanized wafer on the center of the chuck of the spin coater. Press 
the “Vacuum” button on the spin coater to hold the wafer in place. 
13. Carefully pipette 4mL of PDMS onto the center of the wafer. (1mL per 1inch 
wafer diameter). 
14. Close the lid of the spin coater. Select the option to run the spin coater at 
2500RPM for 5 minutes. 
15. Press start and the programmed operation will begin. 
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a. Note: If the screen shows “No Vacuum”  
i. Ensure the vacuum valve is completely open 
ii. Ensure that the “Vacuum” button was pressed 
b. Note: If the screen shows “No CDA” 
i. Ensure that the nitrogen tank reads 60-70 psi. Anything outside 
of this region will prevent the spin coater from operating. 
16. Once the program has ended and the wafer has come to a stop, open the lid of 
the spin coater. Press the “vacuum” button to release the wafer. Remove the 
wafer from the spin coater and take it to the hot plate. 
17. Immediately place the wafer on the hot plate for 2-3 minutes. 
18. Remove the wafer and allow it to cool briefly before placing back inside the 
carrying case. 
19. Turn off the spin coater. Close the vacuum valve in the fume hood. Close the 
nitrogen tank valve. Clean any spills thoroughly. 
20. Do not dispose of the excess PDMS, it will be used to create the edge bead on 









Appendix E: Removal of the Porous Membrane (Sacrificial Layer Technique) 
Goal: Removal of the membrane using the sacrificial layer technique 
Ingredients: 
• Silanized Silicon Wafer and carrying case 
• Tweezers 
• Scalpel  
• Glass container 
• Water 
• Hot plate 
Procedure: 
1. Remove the wafer with the membrane from the carrying case. 
2. Place the wafer in a thin layer of water, enough to completely cover the 
surface. 
3. Place the container on a hot plate and slowly heat to between 95°C and 
150°C. 
4. Wait for the sacrificial layer to dissolve. The membrane should become 
partially detached from the wafer. 
5. Use tweezers to manipulate the membrane as needed. 
6. Place the unfolded membrane in a container with a thin layer of water to 
prevent it from sticking to the container or itself. Place a cover on the 
container or continue to fabrication of completed insert. 
7. Place the wafer back in its case. 
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Appendix F: Removal of the Porous Membrane (Edge Bead Technique) 
Goal: Removal of the membrane using the edge bead and tweezers technique. 
Ingredients: 
• Silanized Silicon Wafer and carrying case 
• Sylgard 184 Elastomer Base (Polydimethylsiloxane (PDMS)) 
• Sylgard 184 Curing Agent 
• Cup, Stirring Rod, and Dropper 
• Oven 
• Tweezers 
• Scalpel  
Procedure: 
1. Remove the wafer with the membrane from the carrying case. 
2. Use the 1mL syringe to pipette a thin bead of PDMS around the edge of 
the wafer. Ensure that there is not an excess of PDMS that will migrate 
towards the center of the wafer. 
3. Place the wafer in the oven at 60°C for 20-30minutes. 
4. Remove the wafer from the oven and briefly allow it to cool. 
5. Cut along the outside of the edge bead with the scalpel or corner of a 
tweezer. 
6. Once the entire perimeter is severed, use tweezers to begin carefully 
peeling the membrane from the surface of the wafer. Use the edge bead for 
initial leverage, and then slowly work the thin segments of the membrane 
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off the wafer. Be careful not to apply too much force, or the membrane 
will rip. 
7. Once the membrane is removed, small amounts of water can be used to 
unfold any folded segments of the membrane. 
8. Place the unfolded membrane in a container with a thin layer of water to 
prevent it from sticking to the container or itself. Place a cover on the 
container or continue to fabrication of completed insert. 
9. Place the wafer back in its case. 














Appendix G: Fabrication of Completed Transwell (Custom Membrane Sample) 
Goal: Procedure to fabricate a completed transwell. This procedure uses a custom 
membrane sample isolated previously. 
Ingredients: 
• Silanized Silicon Wafer and carrying case 
• Sylgard 184 Elastomer Base (Polydimethylsiloxane (PDMS)) 
• Sylgard 184 Curing Agent 
• Cup, Stirring Rod, and Dropper 
• Oven 
• Tweezers 
• Scalpel  
• Biopsy Punch (5mm) 
• Transwell support 
• Membrane 
Procedure: 
1. Place a thin layer of PDMS (mixed at 10:1 ratio) on the stirring stick used 
in its preparation. 
2. Lightly “stamp” the bottom of the support in the PDMS. 
3. Use a 5mm biopsy punch to separate a small amount of the membrane for 
use on the bottom of the transwell. 
4. Carefully isolate this separated membrane region. 
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5. Place the membrane on the stamped area of the support, ensuring that 
there are no gaps and the membrane is fully touching the bottom of the 
support all around. 
6. Place the completed transwell in the 60°C Oven for 2 hours. 
7. Store completed transwell insert in a covered container. 
















Appendix H: Fabrication of Completed Transwell (Commercial Membrane Sample) 
Goal: Procedure to fabricate a completed transwell. This procedure uses a custom 
membrane sample isolated from a commercial membrane. 
Ingredients: 
• Silanized Silicon Wafer and carrying case 
• Sylgard 184 Elastomer Base (Polydimethylsiloxane (PDMS)) 
• Sylgard 184 Curing Agent 
• Cup, Stirring Rod, and Dropper 
• Oven 
• Forceps 
• Scalpel  
• Biopsy Punch (5mm) 
• Transwell support 
• Membrane 
Procedure: 
1. Place a thin layer of PDMS (mixed at 10:1 ratio) on the stirring stick used 
in its preparation. 
2. Lightly “stamp” the bottom of the support in the PDMS. 
3. Use a 5mm biopsy punch to separate a small amount of the commercial 
membrane for use on the bottom of the transwell. 
4. Carefully isolate this separated membrane region. 
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5. Place the membrane on the stamped area of the support, ensuring that 
there are no gaps and the membrane is fully touching the bottom of the 
support all around. 
6. Place the completed transwell in the 60°C Oven for 2-3 hours. 
7. Store completed transwell insert in a covered container. 
















Appendix I: Plasma Treatment Procedure Using Plasma Etcher 
Goal: Procedure to plasma treat the membrane. This ensures that the membrane has a 
hydrophilic surface, making it easier for the collagen and poly-l-lysine to coat the 
surface, ultimately assisting with cell adhesion. This step is only performed on the 
custom membranes. 
Ingredients: 
• Glass petri dish  
• Tape 
• Transwell Inserts 
• Plasma Chamber  
• Oxygen Gas Source 
Procedure: 
1. Cover the inside of the glass petri dish with tape. This will prevent the 
insert or membrane from sticking to the glass. 
2. Place the petri dish inside the plasma chamber with the lid off. Minimize 
the time that the inserts are exposed to the ambient environment. 
3. Close the door to the plasma chamber and activate the vacuum. Ensure 
that the vacuum is active by gently pulling on the door. 
4. Close the ozone generator valve located just after the regulator, and slowly 
open the valve on the gas tank. Ensure the outlet of the tubing is connected 
to the plasma chamber. 
5. Adjust the pressure on the outlet of the regulator to be between 4-6psi.  
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a. Note: This value can differ depending on the operating pressure of 
the plasma chamber. 
6. Open the valve, allowing gas to flow freely from the regulator. 
7. Adjust the settings on the plasma oxidizer and select Medium or High. 
8. Turn on the power supply. 
9. Close the outlet valve on the plasma oxidizer. Allow the gas to flow for 
10-15 seconds. 
10. Close the ozone generator valve located just after the regulator. 
11. Slowly adjust the needle valve on the plasma oxidizer until the readout 
shows a gas pressure between 1300 – 1500 µm. 
12. Allow the plasma treatment to continue for 30 seconds.  
13.  Turn off the power supply. 
14. Rotate the setting dial to “Off”. 
15. Open the ozone generator valve.  
16. Open the plasma chamber valve. 
17. Close the main valve to the gas tank. 
18. Turn off the vacuum. 







Appendix J: UV Treatment on Transwell Inserts 
Goal: A UV treatment is performed on the membrane to ensure that the surface is 
disinfected. This step is performed after the plasma treatment for the custom membrane. 
This step is performed after the completed transwell is prepared for the polyester 
membrane sample. 
Ingredients: 
• Well Plate 
• Custom Transwell Inserts 
• DI H2O 
• UV Light Source 
Procedure: 
1.  Fill wells in the well plate with DI H2O in order to fully submerge inserts. 
2. Place inserts in wells with the membrane facing upward. 
3. Turn on UV light source for 1 hour. 








Appendix K: Collagen and Poly-L-Lysine (PLL) Treatment Procedure 
Goal: This procedure is used to treat the surface of the membrane to assist with cell 
adhesion. This step is only performed for the custom membrane samples. 
Ingredients: 
• Well Plate 
• Custom Transwell Inserts 
• Collagen 
• Poly Lysine 
Procedure: 
1. Dilute the collagen concentration to 5µg/cm2. 10µL will be applied to each 
membrane. 
2. Dilute the PLL concentration to 5µg/cm2. 10µL will be applied to each 
membrane. 
3. Mix the diluted collagen and PLL solutions into a single vial. 
4. Invert all inserts so that the membrane is bottom facing upward. 
5. Apply 20µL of the mixed solution to the surface of the membrane. 
6. Leave the solution overnight. 






Appendix L: Collagen Treatment Procedure 
Goal This procedure is used to treat the surface of the membrane to assist with cell 
adhesion. This step is only performed for the commercial membrane samples. 
Ingredients: 
• Well Plate 
• Custom Transwell Inserts 
• Collagen Solution  
Procedure: 
1. Dilute the collagen concentration to 5µg/cm2. 10µL will be applied to each 
membrane. 
2. Invert all inserts so that the membrane is bottom facing upward. 
3. Apply 10µL of the collagen solution to the surface of the membrane. 
4. Leave the collagen overnight. 









Appendix M: Unfreezing Procedure for Frozen Cell Cultures 
Goal: Procedure for unfreezing cells and starting a fresh culture. 
Ingredients: 
• EMEM Culture Media 
• T25 Culture Flasks 
• 15mL conical tubes 
Procedure: 
1. Clean interior of culture hood with 70% ethanol prior to use. 
2. Warm media for 30min – 1hr. 
3. Place 4mL of media in T25 flask to prepare it for cells. 
4. Move flasks to incubator – let sit for 15min. 
5. Thaw out cells by gently stirring in hot water bath for 2 minutes.  
6. Add 3mL of fresh media to 15mL conical tubes 
7. Add thawed cell suspension to a conical tube 
8. Centrifuge at 1500RPM for 5 minutes 
9. Gently pipette excess media from conical tube, careful not to disturb the 
pellet. 
10. Mix the cell pellet with 550 mL of fresh media 
11. Count cells following cell counting procedure 
12. Pipette the desired number of cells into fresh T25 flask. 
13.  Place reagents back in storage locations. 
14. Clean interior of culture hood with 70% ethanol. 
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Appendix N: Changing Cell Culture Media 
Goal: Refresh media 2-3 times per week. 
Ingredients: 
• EMEM Culture Media 
• Sterile PBS 
• Cell Cultures in T25 Culture Flasks 
Procedure: 
1. Clean interior of culture hood with 70% ethanol prior to use. 
2. Warm reagents for 30min – 1hr 
3. Observe T25 flasks under microscope, check confluence 
4. Remove media using pipette  
5. Wash twice with sterile PBS using pipette 
6. Add 4mL of fresh media with pipette 









Appendix O: Passaging Cell Culture 
Goal: Once cells reach 85% + confluence, passage to another flask. 
Ingredients: 
• EMEM Culture Media 
• Sterile PBS 
• Trypsin 
• Cell Cultures in T25 Culture Flasks 
• T25 Culture flasks 
• 15ml conical tubes 
Procedure: 
1. Clean interior of culture hood with 70% ethanol prior to use. 
2. Warm reagents for 30min – 1hr 
3. Observe T25 flasks under microscope, check confluence 
4. Remove media using pipette  
5. Wash twice with sterile PBS using pipette 
6. Add 1mL of trypsin with pipette 
7. Place cells in incubator for 5 minutes 
8. Add 4mL of fresh media to new culture flask 
9. Remove flask and observe under microscope. Ensure cells are dislodged from the 
flask. 




11. Centrifuge the cell suspension at 1500RPM for 5 minutes. 
12. Remove the excess media and resuspend cells in 550µL of media. 
13. Count cells according to cell counting procedure. 
14. Pipette the desired number of cells into fresh T25 flask. 
15.  Place reagents back in storage locations. 
















Appendix P: Freezing Procedure for Cells 
Goal: Freeze cells for use later. Frozen cells can be stored for long term to preserve 
earlier passages. 
Ingredients: 
• EMEM Culture Media 
• Sterile PBS 
• Freezing Media 
• Trypsin 
• Cell Cultures in T25 Culture Flasks 
• 15ml conical tubes 
• Freezing vials 
Procedure: 
1. Clean interior of culture hood with 70% ethanol prior to use. 
2. Warm reagents for 30min – 1hr 
3. Observe T25 flasks under microscope, check confluence 
4. Remove media using pipette  
5. Wash twice with sterile PBS using pipette 
6. Add 1mL of trypsin with pipette 
7. Place cells in incubator for 5 minutes 
8. Add 4mL of fresh media to new culture flask 




10. Add 3mL of media to the trypsin and remove cell suspension, placing in a 15mL 
conical tube. 
11. Centrifuge the cell suspension at 1500RPM for 5 minutes. 
12. Remove the supernatant and resuspend cells in 550µL of media. 
13. Count cells according to cell counting procedure. 
14. Resuspend cells in freezing media (9:1 ratio of media to DMSO), such that 1 
million cells are present for each 1mL of freezing media. 
15. Place 1mL of cell suspension in each vial. 
16. Label vials and place in -80°C freezer. 













Appendix Q: Procedure for Counting Cells 
Goal: Procedure for using the cell counter to count cells to determine the number of cells 
in the cell suspension. 
Ingredients: 
• EMEM Culture Media 
• Trypan Blue 
• Cell Cultures in T25 Culture Flasks 
• 1mL vial 
Procedure: 
1. Starting with a cell suspension of cells in media. 
2. Pipette 50µL of trypan blue into a 1mL vial. 
3. Pipette 50µL of cell suspension into the 1mL vial. 
4. Ensure thorough mixture of suspension with the trypan blue. 
5. Place 20µL of the mixture in each chamber of the cell counter slide 
6. Select trypan blue viability and run the cell counter procedure. 
7. Record the live cell count, viability %, and repeat the procedure for the second 
chamber of the slide. 
8. Take the average of the two numbers. If there are extreme variations, repeat this 
process. 




Appendix R: Procedure for Seeding Cells on Transwell Membranes 
Goal: Procedure for seeding the cells on the transwell membranes. The most optimal 
seeding density was found to be 625,000 cells/cm2 (200,000cells/well) to reach 
confluence in 7 days. 
Ingredients: 
• EMEM Culture Media 
• Trypsin 
• Cell Cultures in T25 Culture Flasks 
• 1mL vial 
• Clean devices 
• Completed transwell inserts 
• Tweezers 
Procedure: 
1. Clean interior of culture hood with 70% ethanol prior to use. 
2. Warm reagents for 30min – 1hr 
3. Observe T25 flasks under microscope, check confluence 
4. Remove media using pipette  
5. Wash twice with sterile PBS using pipette 
6. Add 1mL of trypsin with pipette 
7. Place cells in incubator for 5 minutes 
8. Add 4mL of fresh media to new culture flask 
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9. Remove flask and observe under microscope. Ensure cells are dislodged from the 
flask. 
10. Add 3mL of media to the trypsin and remove cell suspension, placing in a 15mL 
conical tube. 
11. Centrifuge the cell suspension at 1500RPM for 5 minutes. 
12. Remove the supernatant and resuspend cells in 550µL of media. 
13. Count cells according to cell counting procedure. 
14. Resuspend cells such that the concentration is 200,000cells per 10µL. 
15. Place the treated transwell inserts inverted, so the membrane surface is on top. 
16. Wick any excess PBS left on the surface of the membrane from finishing the 
treatment procedure. 
17. Carefully pipette 10µL of the cell suspension to the center of each membrane. 
18. Cover the samples and place the inserts in the incubator for 1 hour. 
19. After one hour, remove the inserts from the incubator and wick any excess media 
from the surface of the membrane using a gauze sponge. 
20.  Place each insert upright in the insert chambers of the devices, using tweezers to 
handle the inserts. 
21. Add 40µL of media to the apical compartment of each insert. 
22. Place the lid on each device and cover the petri dish. 






Appendix S: Cytoskeleton Immunocytochemistry Procedure 
Goal: Procedure for immunocytochemistry on the RPMI 2650 samples. The β-tubulin 
and actin fibers of the cytoskeleton were targeted to assess changes in the cytoskeleton in 
response to wall shear stresses created by the bi-directional airflow system. 
Immunocytochemistry: 
• Primary antibody (1o):  β-Tubulin (D-10) (sc-5274, Santa Cruz, raised in mouse) 
• Secondary antibody (2o):  Goat anti-Mouse- Alexa Fluor® 488 (Invitrogen – 
fridge) 
• Phalloidin- Alexa Fluor 594 (freezer box) 
• DAPI 
Solutions: 
• Permeabilization Solution  
o 0.2% Triton® X-100 and 0.1% BSA agent in PBS 
• Blocking Buffer (BB) 
o 10% BSA and 0.2% Triton® X-100 
• Primary Antibody (1o) Solution 
o 1:100 or 1:200 of β-Tubulin to BB 
o Use total volume of BB enough for 200 µL/cm2 for each well surface 
• Secondary Antibody (1o) + Stain Solution 
o 1:500 of Goat anti-Mouse- Alexa Fluor® 488 to BB  
o 1:40 of Phalloidin- Alexa Fluor 594 to BB 
o Use total volume of BB enough for 200 µL/cm2 for each well surface 
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• DAPI Solution 
o Dilute DAPI to 1 µg/mL in BB 
o Use total volume of solution enough for 200 µL/cm2 for each well surface 
Procedure: 
1. Add permeabilization solution to each well. Incubate for 20 min at RT on rotating 
plate. 
2. Remove permeabilization solution.  Wash 3 times with 1 X PBS (4 min each wash).  
3. Add blocking buffer to each well. Incubate for 1 hour at RT on rotating plate. 
4. Aspirate to remove the blocking buffer.  
5. Add the primary antibody (1o) solution to the designated wells. Incubate for 1.25-
1.5h on rotating plate at RT.  
6. Remove the primary antibody (1o) solution. Wash 3 times with PBS. (4 min each, at 
T, on rotating plate).  
7. Add the secondary antibody (1o) + stain solution to wells.  Incubate for 1.5h on 
rotating plate at RT. Protect from light. 
8. Remove secondary antibody (1o) + stain solution to wells.  Wash 3 times with PBS 
(4 min each, at RT, on rotating plate). 
9. Add DAPI solution. Incubate for 10 min at room temperature on rotating plate. 
Protect from light.  




11. Add samples to mounting coverslips and mount.  Make sure substrates are flat and 
that there are no bubbles (can let set for few minutes to allow bubbles to de-gas 



















Appendix T: Alcian Blue and Nuclear Fast Red Procedure: 
Goal: After running experiments using custom transwell inserts with RPMI 2650 cells, 
Alcian Blue is used to stain mucin proteins in the mucus produced on the surface of the 
cells. The darker the blue of the stain, the more mucins are present in that region. Nuclear 
fast red is used as a counterstain for increased cell visibility. 
Reagent Preparation 
➢ 3%(v/v) acetic acid/water 
o Mix glacial acetic acid with distilled water to create 3%(v/v) solution. 
➢ Alcian Blue stain (pH of 2.5) 
o Mix Alcian Blue Powder (1%(w/v)) in 3%(v/v) acetic acid/water. 
o Ensure pH of 2.5. Add additional 3% Acetic acid as needed. 
Alcian Blue and Nuclear Fast Red Staining Preparation 
➢ Prepare a 96 well plate to be used for experiments. 
➢ Total Reagents used (per insert): 
o PBS: 100µL 
o PFA: 240µL 
o 3% Acetic Acid: 720µL 
o Alcian Blue Stain (pH of 2.5): 240µL 
o Nuclear Fast Red: 240µL 
➢ Repeat this procedure and prep a row on the well plate for each insert being 
processed. 
o Place 200µL of PFA in Column 3. 
114 
 
o Place 200µL of 3% Acetic Acid in Column 4. 
o Place 200µL of Alcian Blue Stain in Column 5. 
o Place 200µL of 3% Acetic Acid in Column 6. 
o Place 200µL of Nuclear Fast Red in Column 7. 
o Place 200µL of 3% Acetic Acid in Column 8. 
 
Figure 35: Diagram of solution positions within the 96 well plate, for the Alcian Blue and Fast Red Assay 
Procedure: 
1. Wash inside compartment of insert with 40µL of PBS and remove with pipette. 
2. Place 40µL of 4% (v/v) paraformaldehyde in the upper compartment of insert. 
3. Fix by placing insert in 4% (v/v) paraformaldehyde (Column 3) for 20 min. 
4. Remove insert and wick excess from inside compartment of insert. 
5. Place 40µL of 3% acetic acid in the upper compartment of insert. 
6. Wash by placing insert in 3% acetic acid (Column 4) for 3 minutes. 
7. Remove insert and wick excess from inside compartment of insert. 
8. Place 40µL of alcian blue stain in the upper compartment of insert. 
9. Stain placing insert in alcian blue stain (Column 5) for 30 min. 
10. Remove insert and wick excess from inside compartment of insert. 
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11. Place 40µL of 3% acetic acid in the upper compartment of insert. 
12. Wash insert by placing in 3% acetic acid (Column 6) for 5 min. 
13. Remove insert and wick excess from inside compartment of insert. 
14. Place 40µL of Nuclear Fast Red in the upper compartment of insert. 
15. Stain placing in Nuclear Fast Red (Column 7) for 5 min. 
16. Remove insert and wick excess from inside compartment of insert. 
17. Place 40µL of 3% acetic acid in the upper compartment of insert. 
18. Wash insert by placing in 3% acetic acid (Column 8) for 3 min. 
19. Remove insert and wick excess from inside compartment of insert. 
20. After membrane has dried, remove membrane from insert using scalpel. 
(Alternatively, membranes can be left on the support for imaging, skipping steps 
21 and 22.) 
21. Place on blank microscope slide and add 6µL of mounting medium. Ensure no 
bubbles. 
22. Add a cover slip over the samples and press down lightly, ensuring seal with 
mounting medium. 








Appendix U: Alcian Blue Assay Procedure: 
Goal: After running experiments using custom transwell inserts with RPMI 2650 cells, 
Alcian Blue is used to stain mucin proteins in the mucus produced on the surface of the 
cells. The darker the blue of the stain, the more mucins are present in that region. Nuclear 
fast red can be used as a counterstain for increased cell visibility. 
Reagent Preparation 
➢ 3%(v/v) acetic acid/water 
o Mix glacial acetic acid with distilled water to create 3%(v/v) solution. 
➢ Alcian Blue stain (pH of 2.5) 
o Mix Alcian Blue Powder (1%(w/v)) in 3%(v/v) acetic acid/water. 
o Ensure pH of 2.5. Add additional 3% Acetic acid as needed. 
Alcian Blue Staining Preparation 
➢ Prepare a 96 well plate to be used for experiments. 
➢ Total Reagents used (per insert): 
o PBS: 100µL 
o PFA: 240µL 
o 3% Acetic Acid: 720µL 
o Alcian Blue Stain (pH of 2.5): 240µL 
➢ Repeat this procedure and prep a row on the well plate for each insert being 
processed. 
o Place 200µL of PFA in Column 3. 
o Place 200µL of 3% Acetic Acid in Column 4. 
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o Place 200µL of Alcian Blue Stain in Column 5. 
o Place 200µL of 3% Acetic Acid in Column 6. 
o Place 200µL of 3% Acetic Acid in Column 7. 
 
Figure 36: Diagram of solution positions within the 96 well plate, for the Alcian Blue Assay 
Procedure: 
1. Wash inside compartment of insert with 40µL of PBS and remove with pipette. 
2. Place 40µL of 4% (v/v) paraformaldehyde in the upper compartment of insert. 
3. Fix by placing insert in 4% (v/v) paraformaldehyde (Column 3) for 20 min. 
4. Remove insert and wick excess from inside compartment of insert. 
5. Place 40µL of 3% acetic acid in the upper compartment of insert. 
6. Wash by placing insert in 3% acetic acid (Column 4) for 3 minutes. 
7. Remove insert and wick excess from inside compartment of insert. 
8. Place 40µL of alcian blue stain in the upper compartment of insert. 
9. Stain placing insert in alcian blue stain (Column 5) for 30 min. 
10. Remove insert and wick excess from inside compartment of insert. 
11. Place 40µL of 3% acetic acid in the upper compartment of insert. 
12. Wash insert by placing in 3% acetic acid (Column 6) for 5 min. 
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13. Remove insert and wick excess from inside compartment of insert. 
14. Place 40µL of 3% acetic acid in the upper compartment of insert. 
15. Wash insert by placing in 3% acetic acid (Column 7) for 3 min. 
16. Remove insert and wick excess from inside compartment of insert. 
17. After membrane has dried, remove membrane from insert using scalpel. 
(Alternatively, membranes can be left on the support for imaging, skipping steps 
18 and 19.) 
18. Place on blank microscope slide and add 6µL of mounting medium. Ensure no 
bubbles. 
19. Add a cover slip over the samples and press down lightly, ensuring seal with 
mounting medium. 












Appendix V: Membrane Porosity Analysis on ImageJ 





1. Open ImageJ software. 
2. Open desired membrane sample image within ImageJ. 
3. Select Image, Type, 32Bit. 
4. Select Image, Adjust, Threshold, and adjust until only the pores are colored. 
5. Select Apply and deselect “Set background pixels to NaN”. Select OK. 
6. Select Analyze, Measure, and view the % Area. This is the porosity, as only the 
pores are selected. 









Appendix W: Alcian Blue Color Density Mapping Procedure 
Goal: ImageJ and Color Inspector 3D were used to analyze the alcian blue images 
obtained after experiments. Color density mapping was performed to determine the 
density of darker and lighter blue colors in each image. 
Tools: 
• ImageJ 
• Color Inspector 3D Plugin 
Procedure: 
1. Open ImageJ software. 
2. Open desired sample image within ImageJ. 
3. Select Plugins, Color Inspector 3D. 
4. Adjust Display Mode (All Colors, Histogram, Median Cut) as needed. 
5. For Histogram, Number of Color Cells was set to maximum. 
6. For Median Cut, Number of Colors was set to 256. 
7. To export the desired cube plot, select File, Save Visualization. 
8. “LUT” opens the lookup table. This is valuable as it provides the Red, Green, 
Blue, Frequency and % Density information for each color sphere within the plot. 






Appendix X: Alcian Blue Mucus Quantification Procedure 
Goal: ImageJ and Color Inspector 3D were used to analyze the alcian blue images 
obtained after experiments. Color density mapping with the median cut function was used 
to quantify the density of darker and lighter blue colors in each image. 
Tools: 
• ImageJ 
• Color Inspector 3D Plugin 
Procedure: 
1. Open ImageJ software. 
2. Open desired sample image within ImageJ. 
3. Select Plugins, Color Inspector 3D. 
4. Select Median Cut in the Display Mode. 
5. Select 10 for Number of Colors. 
6. Assign each circle a category (Dark Blue, Light Blue, Background) based on its 
hue. 
7. Highlight each of the colors in the image and record the % Density for each of the 
colors and add it to the total density within the respective category. 






Appendix Y: Photolithography Procedure for Wafer Development 
Goal: Procedure for creating the wafer mold that is used to produce the PDMS 
membranes. This procedure leads to the creation of SU8-50 micro-posts on the surface of 
a silicon wafer. 
Procedure: 
1. Perform cleaning on wafer using oxide etch or piranha etch for 20 minutes. 
2. Dry with Nitrogen gun and place on 95°C hot plate for 5 minutes. 
3. Drop 4mL of SU8-50 Photoresist onto the wafer surface. 
4. Spin coat at 500 RPM for 10 seconds, then 2150 RPM for 30secs. 
5. Remove the edge bead using a foam tipped rod. 
6. Perform soft bake on hot plate at 65°C for 6 minutes. 
7. Continue soft bake on hot plate at 95°C for 20 minutes. 
8. Position mask in the mask aligner. Position wafer in mask aligner. 
9. Expose the SU8-50 to near UV radiation with an energy of 220mJ/cm2. 
a. 2 cycles were used, with 5 second delay between. 
10. Perform post exposure bake on hot plate at 65°C for 1 minute. 
11. Continue post exposure back on hot plate at 95°C for 5 minutes. 
12. Place wafer in the SU8-50 developer for 6 minutes. 
13. Move to a fresh developer dish for 4 minutes. 
14. Rinse the wafer with isopropyl alcohol. 
15. Clean the surface of the wafer with the Nitrogen gun. 
16. Place the finished wafer in a container to protect it from contaminates. 
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Appendix Z: Bi-Directional Air Delivery System Operational Protocol 
Goal: Procedure for operating the Bi-directional air delivery system. 
Procedure: 
1. Power on the incubator. Allow it to reach 37°C. It takes ~1 hour to stabilize near 
37°C and ~8 hours to stabilize on 37°C. 
2. Place an empty testing device within the incubator and attach it to the air tubing. 
3. Plug in the Arduino RH and Temperature sensor. 
4. If needed, connect a PC with Arduino software to the solenoid valve circuit.  
a. Select the desired inhalation, exhalation, and resting periods 
b. Upload the new code to the Arduino 
c. Disconnect the PC from the Arduino. 
5. Turn on the solenoid valve circuit. 
6. Turn on the flow controller. 
7. Remove the base of the first bubbler chamber and fill it with the desired amount 
of water. Place the base back on the bubbler chamber. 
8. If needed, turn on the hot plate and select the desired temperature. Place the first 
bubbler chamber on the hot plate surface. 
9.  Open the main valve on the gas tank. 
10. Slowly open the valve on the regulator, establishing a pressure of 6-10psi.  
11. Allow the gas to run for 30minutes to 1 hour to stabilize the temperature and 
humidity of the air flow. 
12. Once the temperature and humidity of the airflow have stabilized, place a device 
containing cell cultures within the incubator and attach it to the system. 
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13. Allow the experiment to run for the full duration. 
14. Once complete, remove the device. A new device can be placed within the 
system, or shutdown procedures can begin. 
15. To shut down, begin by closing the main valve on the gas tank. 
16. Allow the pressure to reach 0 on the tank regulator gauge, and slowly close the 
regulator valve. 
17. Turn off the solenoid valve circuit 
18. Turn off the flow controller. 
19. Turn off the hot plate. 
20. Turn off the temperature and humidity sensor. 
21. If not using the incubator again within 3-4 days, turn off the incubator. 












Appendix AA: Bi-Directional Air Delivery System, Solenoid Valve Circuit and 
Arduino Code 
Description: The circuit features 5 solenoid valves, allowing for precise control over air 
flow through the system. These valves are controlled using Arduino UNO code to mimic 
a square wave breathing pattern. 
 















Appendix AB: Humidity and Temperature Monitoring System, Circuit and 
Arduino Code 
Description: Humidity and temperature sensor integrated with an Arduino UNO. The 
circuit is designed to feature a readout on an LCD screen and a potentiometer to control 
the screen brightness and contrast. The code connects to the DHT11/22 database, 
allowing precise monitoring of temperature and humidity. 
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